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ABSTRACT 
 
Neuropsychological and Emotion Processing Abnormalities  
In Bipolar Disorder I and II 
 
by 
 
Carol Randall 
 
Dr. Daniel N. Allen, Examination Committee Chair 
Professor of Psychology 
University of Nevada, Las Vegas 
 
Bipolar disorder illness is marked by emotional lability and mood disturbance, as 
well as various neuropsychological deficits, and the neuroanatomical correlates of many 
of these deficits are beginning to be identified. Numerous studies have implicated 
specific cortical and sub-cortical abnormalities in areas associated with executive 
function, memory, motor function, and the processing of emotion. Although a large body 
of research has been devoted to the investigation of cognitive and emotion-processing 
deficits in bipolar disorder, relatively few studies have been devoted to the investigation 
of how these deficits differ among bipolar disorder subtypes. This is surprising in light of 
known symptomatological and phenomenological differences found among the illness 
subtypes.  Moreover, the nosological status of bipolar disorder is still considered by 
many to be uncertain. The aim of this study is to address these ongoing issues by 
investigating and comparing emotion processing and neuropsychological deficits among 
bipolar I disorder, bipolar II disorder, and healthy control groups to further clarify the 
nature and extent of differences in impairment among these groups.  
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CHAPTER 1 
INTRODUCTION 
 
A growing body of research is clarifying understanding of the various psychosocial, 
neurocognitive, and emotion processing deficits associated with bipolar disorder (Van 
Gorp, Altshuler, Dixon, & Theberge, 1996; Gourovitch, Torrey, Gold, Randolph, 
Weinberger, & Goldberg, 1999; Ferrier & Thompson, 2002; Phillips, Drevets, Rauch, & 
Lane, 2003).  Many of these studies have also provided evidence of abnormalities of 
specific brain structures that are critical for the normal processing of information, 
including those that underpin the processing of emotion. In considering the integral 
nature of emotion processing in learning and memory, it is logical to assume that 
impairments in the processing of emotion likely contribute to the extent and nature of 
dysfunction commonly found in those with bipolar disorder. An accurate 
conceptualization of the nature and extent of the neurocognitive and emotion processing 
abnormalities associated with bipolar disorder has significant implications for those with 
the illness.  
The potential benefits of increased understanding of the functional and structural 
abnormalities associated with bipolar disorder could lead to a refinement of the 
diagnostic criteria and facilitate earlier detection, more accurate diagnoses, improvement 
in treatment outcomes, and possibly even the development of prophylactic interventions 
for those at risk for this debilitating illness. More importantly, such an expansion of this 
knowledge base may serve to alleviate the human suffering and financial burden often 
realized by individuals, families, and communities as a result of the disorder.    
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Despite the chronic illness course inherent in bipolar disorder as well as clear 
differences among BP subtypes with regard to symptom presentation, age of onset, and 
prevalence rate, research has only recently turned attention to an examination of how 
neurocognitive and emotion processing deficits may differ among the subtypes.   
The main purpose of this study is to investigate how neurocognitive and emotion 
processing profiles differ in bipolar disorder as compared to healthy populations. 
Differential patterns of performance in bipolar I disorder and bipolar II disorder 
populations were also investigated to determine whether performance measures are 
consistent with a spectrum conceptualization of bipolar disorder or whether these 
measures indicate distinct disorders among the subtypes. Considering the extant 
literature, it was predicted that the combined bipolar disorder groups would demonstrate 
a significant degree of impairment in working memory, verbal learning and memory, 
executive function, and emotion processing as compared to a normal control group. It 
was also hypothesized that the bipolar I disorder group would demonstrate a 
quantitatively greater degree of impairment in these domains as compared to the bipolar 
II disorder group, with the bipolar II disorder group performing at an intermediate level 
of performance between the bipolar I disorder and the normal control group, thus 
supporting a spectrum conceptualization of bipolar disorder illness.  
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CHAPTER 2 
LITERATURE REVIEW 
Bipolar disorder (BP) is a severe and debilitating mental disorder characterized by 
perceptual, affective, behavioral, cognitive, and psychosocial impairment.  Due to the 
phenomenological variability found in BP, with illness course, symptom presentation and 
functional impairment in BP differing widely among individuals and across time, the 
disorder is often misdiagnosed and perhaps even more often inadequately treated. This is 
unfortunate considering the high degree of morbidity and chronicity often associated with 
the illness. 
Lifetime prevalence rate estimates range from .4% to 1.6% in individuals with bipolar 
I disorder (BPI) and from .5% to as much as 5% in individuals with bipolar II disorder 
(BPII), (Berk & Dodd, 2005).  BP appears to be distributed rather evenly among the 
genders, although there is some evidence that symptom presentation may differ to some 
degree as a function of sex.  In males, the first episode is more often a manic episode, and 
manic episodes tend to predominate over the illness course.  In contrast, the first episode 
among women is more often a major depressive episode, and major depressive episodes 
tend to predominate. This is an interesting finding and may indicate that women in 
general are at particular risk for depression. There is also some evidence suggesting that 
women experience more rapid cycling than do men. This is of note in that rapid cycling, 
which is characterized by the presence of four or more major depressive, manic, 
hypomanic, and/or mixed episodes in a twelve-month period, is associated with poorer 
prognosis (DSM-IV, 1994). 
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Research has indicated the presence of a strong genetic component in BP with higher 
rates of the disorder being found in first-degree biological relatives of individuals with 
BPI (4% - 24%) and individuals with BPII (1% - 5%).  Although no specific genetic 
markers have been definitively identified, multiple regions on the human genome are 
indicated for genetic risk. One genetic study, in which 7 pairs of monozygotic twins 
discordant for BP were investigated, the unaffected twins demonstrated cognitive 
impairment in relation to a control group on various measures of memory.  This finding 
may indicate a genetic predisposition or vulnerability and reaffirms the assertion of a 
strong genetic component in the disorder.   
According to DSM-IV criteria, a diagnosis of BPI is made when the occurrence of 
one or more manic or mixed episodes, exclusive of any substance- or medically- induced 
mood disorder is established (DSM-IV, 1994).  In the DSM-IV, a  manic episode is:  
“…a distinct period of abnormally and persistently elevated, expansive, or 
irritable mood, lasting at least one week (or any duration if hospitalization is 
necessary)” (p.  362).   
Symptoms commonly associated with a manic episode include inflated self-esteem, a 
marked or decreased need for sleep, pressured speech, a flight of ideas, racing thoughts, 
distractibility, agitation, and increased involvement in destructive or personally harmful 
behaviors.  Additionally, individuals with BPI usually experience one or more major 
depressive episodes, although the occurrence of such episodes is not necessary for a 
diagnosis of BPI to be made. Major depressive episodes are characterized by 2-weeks or 
more of persistently depressed mood and/or a loss of interest or pleasure in normal 
activities and commonly include irritability, significant weight loss or gain, decreased or 
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increased appetite, hypersomnia or insomnia, psychomotor agitation or retardation, 
fatigue, inability to concentrate, indecisiveness, feelings of worthlessness or guilt, 
thoughts of death, and suicidal ideation (p. 356).  A mixed episode is characterized by a 
period of at least a week in which the patient meets criteria for both a manic and a major 
depressive episode (p. 365).  
BPII, which is generally considered to be a milder form of the disorder and which 
according to some studies occurs more frequently in the population (Kessler, 
McGonagle, Zhao, Nelson, Hughes, Eshleman, Wittchen, & Kendler, 1994), was 
originally classified as bipolar disorder NOS in the DSM-IIIR and did not achieve its 
official title until publication of the DSM-IV in 1994.  According to the DSM-IV, a 
diagnosis of BPII is given when an individual has experienced at least one major 
depressive episode, has had at least one hypomanic episode, and has never experienced a 
manic or mixed episode.  Hypomanic episodes are similar in symptomology to manic 
episodes, although episodes are "not severe enough to cause marked impairment in social 
or occupational functioning, or to necessitate hospitalization, and there are no psychotic 
features." Additionally, time criterion for persistence of symptoms for a hypomanic 
episode is four days as opposed to one week as required for mania (p. 368).   
The literature remains divided with regard to the nosological status of BP illness, with 
some conceptualizing a “bipolar spectrum” (Klerman, 1981; Akiskal, 2002) or 
dimensional model, with BPII representing a milder form of the disorder (Serretti & 
Olgiati, 2005) and others arguing that BPI and BPII are better conceptualized as separate 
and distinct disorders (Harkavy-Friedman, Keilp, Grunebaum, Sher, Printz, Burke, Mann 
& Oquendo, 2006). Relatively few studies, however, have directly investigated 
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neurocognitive deficit differences in BPI and BPII. This is unfortunate in that there is 
some evidence suggesting that those with BPII may experience a more chronic course of 
illness, demonstrate greater risk for suicide, experience significantly more hypomanic 
and depressive episodes, and have shorter interepisode intervals than those with BPI 
(Judd, Akiskal, Schettler, Coryell, Maser, Rice, Sollomon & Keller, 2003; Joffe, 
MacQueen, Marriott & Young, 2004).  For example, findings from a study in which self-
perception in BP was investigated suggest that BPII may be associated with a lower 
degree of insight and illness awareness, a higher degree of relapse, more familial 
dysfunction, and higher rates of affective disorders within families than is BPI (Pallanti, 
Quercioli, Pazzagli, Rossi, Dell‟Osso, Pini & Cassano, 1999). In a review of suicidal 
behavior among BPI, BPII, and MDD populations, researchers found evidence that the 
rate of suicide attempt may be higher in BPII than BPI. The study also indicated that 
BPII may be overrepresented among depressed suicide victims.  
In that hypomanic episodes lack marked impairment and are often experienced as 
egosyntonic, those with BPII rarely seek treatment until in a major depressive episode, 
which no doubt contributes to the high rate of  misdiagnosis and underdiagnosis of this 
subtype.  Considering these factors, it is not hard to understand the difficulty associated 
with classification and accurate diagnosis of bipolar disorder subtypes. Findings of a 
study in which BP patients from the community were investigated highlight this 
difficulty. Within the sample, roughly 70% of BP subjects had previously been 
misdiagnosed. Of those who had received an incorrect diagnosis, 60% had been 
diagnosed with major depressive disorder, with 33% maintaining this incorrect diagnosis 
for 10 years or more. Moreover, these patients had over the years received an average of 
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3.5 additional incorrect diagnoses and had been seen by an average of four physicians 
before being correctly diagnosed (Hirschfeld, Lewis & Vornik, 2003). As clarified by 
this study, BP depression is frequently diagnosed and treated as unipolar depression. This 
is unfortunate in light of the potential dangers associated with the misdiagnosis and 
incorrect treatment of BP, which include possible triggering of manic episodes in 
individuals with BPI when given antidepressants without accompanying mood stabilizers 
and a poor track record for antidepressant therapy in the treatment of BP depression. 
 
Neuroanatomical Abnormalities 
 
Various structural and functional brain abnormalities appear to be associated with the 
pathophysiology of BP, and technological advances in neuroimaging are providing 
increasingly powerful and noninvasive means to view chemical, structural, and functional 
aspects of brain and neural circuitry specific to BP, frequently without the use of ionizing 
radiation. The most commonly used modalities to date include Magnetic Resonance 
Imaging (MRI), which uses a magnetic field to align atoms and reveal contrasts in the 
different soft-tissues of the brain, Functional Magnetic Resonance Imaging (fMRI), 
which monitors neural activity by measuring hemodynamic responses or changes in 
blood-flow in brain regions, Magnetization Transfer Imaging (MTI), which is a 
quantitative MRI technique that utilizes the presence or absence of macromolecules in 
brain tissue membranes to view neuroanatomy, Diffussion Tensor Imaging (DTI), a 
variation of MRI technology with which subtle brain circuitry and connections between 
different brain areas can be observed, Positron Emission Tomography (PET), which uses 
gamma rays to produce a three-dimensional image of functional brain processes, Single 
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Photon Emission Computed Tomography (SPECT), which uses small amounts of 
radioactive isotypes to measure neuronal changes, and Voxel-Based Morphometry 
(VBM), which uses statistical parametric mapping to view focal brain tissue differences. 
These technologies are proving to be powerful tools in the search for specific BP 
endophenotypes. In the pursuit of BP-specific functional and structural abnormalities, 
science continues to add to our BP knowledge base by linking abnormalities observed 
with the use of these neuroimaging techniques to core domains of BP pathology that 
points to the identification of endophenotypic markers for the illness. It is hoped that the 
identification of BP specific markers will serve to facilitate differential diagnosis, earlier 
illness detection, and the identification of at-risk populations for early intervention in BP. 
Structural Imaging 
Structural imaging studies have demonstrated robust changes in numerous cortical 
regions, although there has been some inconsistency across studies (McDonald, Zanelli, 
Rabe-Hesketh, Ellison-Wright, Shama, Kalidindia, Murray, & Kennedy, 2004; Kempton, 
Geddes, Ettinger, Williams, & Grasby, 2008; Konarski, Mcintyre, Kennedy, Rafi-Tari, 
Soczynska, & Ketter, 2008). Nonetheless, changes have been consistently observed even 
in the early course of the illness in BP (Hajek, Carrey, & Alda, 2005; Pfeifer, Welge, 
Strakowski, Adler, & DelBello, 2008). These early structural changes indicate that 
neuroanatomical abnormalities are not simply the sequelae of illness morbidity, recurrent 
mood episodes, or pharmacotherapy. Findings postmortem investigations have also 
consistently demonstrated structural pathology in BP and include neuronal size 
abnormalities as well as glial cell density reductions in various prefrontal and subcortical 
areas (Rajkowska, 2002). 
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Structural neuroimaging studies indicate the presence of abnormal grey matter 
densities within various cortical structures in BP and other mood disorders. In an MRI 
study in which subcortical grey matter brain regions in adolescents with BP were 
investigated, results revealed enlarged putamen in BP adolescents as compared to NC 
adolescents (DelBello, Zimmerman, Mills, Getz, & Strakowski, 2004).  A similar study 
found an inverse correlation between putamen matter volumes and age in individuals 
with BP, and an association between duration of illness and putamen volumes was 
indicated, with those reporting a shorter duration of illness showing smaller putamen 
volumes (Brambilla, Harenski, & Nicoletti, 2001).  The putamen, a rounded structure 
located at the base of the telencephalon or forebrain and part of the dorsal striatum and 
basal ganglia, utilizes dopamine projections to perform its functions in the regulation of 
movements and in influencing certain types of learning. A recent study found evidence 
that the putamen (in conjunction with the caudate nucleus and pulvinar) is also part of a 
cortico-subcortical anatomical
 
network that when damaged leads to spatial neglect in 
humans (Karnath, Himmelbach, & Rorden, 2002). 
Perhaps the most consistent findings of structural neuroimaging studies in BP have 
been abnormalities of limbic system structures in those with BP. In one such study, 
anterior cingulate grey matter reductions were found in BP subjects who were in remitted 
or euthymic states of the illness (Drevets et al., 1997).  The anterior cingulate gyrus is a 
brain region thought to play a role in a variety of autonomic functions, including blood 
pressure and heart rate regulation, as well as various social and cognitive functions such 
as social reciprocity, decision making, anticipation of reward, empathy, and the 
production of emotion. In a recent study in which the anterior cingulate gyri of male 
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macaque monkeys were lesioned, the damaged monkeys lost the interest or ability for 
social interaction with female macaques (Rudebeck, Buckley, Walton & Rushworth, 
2006).  In that the subjects in the former BP study were in euthymic phases of BP illness 
at the time of imaging, the grey matter anterior cingulate reductions found may represent 
a BP trait deficit, which could explain some of the social dysfunction often realized by 
those with BP.  
One study reported reduction of thalamic volume in BP adolescents (Dasari et al., 
1999), and others have reported amygdalar abnormalities. These findings have been 
varied however with regard to abnormality specifics, with some studies finding amydalar 
enlargement and others finding volumetric reductions in BP patients (Berns, Martin, & 
Proper, 2002; DelBello, Zimmerman, Mills, Getz, & Strakowski, 2004; Strakowski, 
DelBello, & Sax et al, 1999). Studies have also varied as to which portions of the 
amygdala are affected in BP, with some studies reporting bilateral enlargement and 
others finding enlargement only in the left hemisphere (Strakowski et al., 1999; Altshuler 
et al., 2000; Frangou et al., 2002; Brambilla et al., 2003). The amygdala, which is 
involved in the identification of the emotional significance of stimuli as well as in the 
encoding and retrieval of emotional information in memory processes, has been 
identified by LeDoux (1996) as the most central structure in the processing of emotion. 
In light of BP symptomatology, the amygdala and other limbic structures have been the 
target of BP investigation for quite some time, and research findings of amygdala and 
other limbic structural abnormalities in BP are no surprise. One study in which limbic 
structures in BP subjects were investigated found evidence that suggests amygdala 
volume may be associated with symptom severity and/or illness chronicity, as greater 
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volume reductions were found in BP subjects who had experienced multiple manic 
episodes as compared to first break manic patients (Strakowski et al., 2002).   
Various studies have also found evidence of prefrontal cortex abnormalities as well as 
abnormalities in the prefrontal-limbic pathways in those with BP (Haldane & Fangou, 
2004; Berns, Martin, & Proper, 2002). One study found significant grey matter 
reductions in the left dorsolateral prefrontal cortex in unmedicated BP subjects as 
compared to a NC group. A trend in the same direction was also found in the right 
dorsolateral prefrontal cortex of the subjects (Brambilla et al., 2002). The dorsolateral 
prefrontal cortex is the highest cortical area of the brain and is involved in the most 
complex aspects of cognition, including manipulation of sensory information in working 
memory, the integration of sensory and mnemonic information, planning of deliberate 
action and motor movement, and organizational and regulatory aspects of emotional and 
intellectual functioning. Dorsal, ventral, and orbital prefrontal cortical grey matter 
volume reductions have also been reported by various neuroimaging studies in BP 
(Lopez-Larson et al., 2002; Frangou et al., 2002).   
The various structural abnormalities found in these studies are consistent with BP 
symptomatology and have added significantly to our knowledge base and understanding 
of the phenomenology specific to BP, such as emotional lability, distractibility, and 
memory disruption (Lyoo, Kim, Stoll, Demopulos, Parow, Dager, Friedman, Dunner, & 
Renshaw, 2004; Altshuler, Bartzokis, Grieder, Curran, & Mintz, 1998; Phillips et al., 
2003; Bertolino, Frye, Cilicott, Mattay, Rakow, Shelton-Repella, Post, & Weinberger, 
2003; Bremner, Narayan, Anderson, Staib, Miller, & Charney, 2001; Bearden, Hoffman, 
& Cannon, 2001).  
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Findings of various structural imaging studies suggesting that BP medications, such 
as Lithium, may increase grey matter volumes provide a sense of hope for those with BP 
(Moore et al., 2000; Sassi et al., 2002). The general belief regarding these findings is that 
medications such as Lithium have neurotrophic effects and increase bcl-2, a 
neuroprotective protein (Manji et al., 1999). A study in which unmedicated verses 
medicated BP patients showed increased grey matter reductions in the posterior cingulate 
cortex lends support to this assertion (Nugent, Milham, & Bain, 2006). If correct, the 
clinical importance of mood stabilizers in providing neuroprotection to those with BP 
cannot be overstated, and this importance is highlighted by research findings that show 
greater age-related neural atrophy and grey matter decline in individuals with BP than is 
found in the general population (Brambilla et al., 2001).  
Various neuroimaging studies have also indicated the presence of white matter 
volumetric reductions in BP (Strakowski et al., 1993; Zipursky et al., 1997; Brambilla et 
al., 2001). BP MRI studies have also found evidence of deep white matter hyperintensity 
lesions involving numerous abnormal neuronal signaling cascades and interrelated 
processes of glutamatergic neurotransmission, altered neurotrophin signaling, abnormal 
mitochondrial function, calcium influx alterations, and oxidative stress (an imbalance 
between reactive oxygen production and the system‟s detoxification capacity and/or 
ability to readily repair resulting damage), (Schloesser, Huang, Klein, & Manji, 2007; 
Kato, 2008; Quiroz, Gray, Kato, & Manji, 2008; Ng, Berk, Dean, & Bush, 2008; Stork & 
Renshaw, 2005; Zarate, Du, Quiroz, Gray, Denicoff, Singh, Charney, & Manji, 2003). 
Findings of glutamatergic system abnormalities in BP, and other disorders that are 
marked by mood disturbance, are thought to be associated with problems in cellular and 
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synaptic resilience and plasticity. These abnormalities are in turn are thought to play a 
major role in the pathophysiology of BP, as preliminary study findings indicate that 
glutamatergic systems are the target for the actions of some antidepressants and mood 
stabilizers used in the treatment of BP (Zarate, Du, Quiroz, Gray, Denicoff, Singh, 
Charney, & Manji, 2003).  Abnormalities in molecular processes (second messenger 
metabolism alterations, cellular membrane abnormalities, changes in the molecular 
processes involving energy in the formation and breakdown of chemical bonds, etc.) have 
been identified within the prefrontal cortex, striatum, and other brain regions in BP and 
are consistent with the idea that decreased neural plasticity and synaptic resilience are 
part of BP pathophysiology  (Schloesser, Huang, Klein, & Manji, 2007).  
Deep white matter lesions, which are seen as bright spots in T2-weighted MRI scans 
and indicative of axonal injury, are sometimes referred to as “brain rust” and are thought 
to be ischemic in etiology and evidence of vascular degeneration, similar to what is 
typically found in aging populations and those with chronic cardiovascular disease 
(Dupont et al., 1987, 1995; Swayze et al., 1990; Figiel et al., 1991; Altshuler et al., 1995; 
McDonald et al., 1999). Additionally, these hyperintensities are thought to be associated 
with vulnerability for the development of late-life depression, greater impairment in 
executive functioning, more severe disability, poorer outcome and quality of life, and 
greater illness chronicity in BP (Moore et al., 2001; Yuan, Salvadore, Li, Zhang, Du, 
Chen, & Manji, 2009).   
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A meta-analysis found older BP subjects to have an increased number of these white 
matter hyperintensities as compared to younger BP and older NC subjects (although they 
have been found to some degree in all BP populations), and those with a BPI diagnosis 
are significantly more likely to develop white matter hyperintensities than are those with 
BPII (Altshuler et al., 1995; Botteron et al., 1995; Lyoo et al., 2002; Pillai et al., 2002). 
However, findings of a recent study which suggest that Valproic Acid may attenuate 
white matter intensities in those with BP as well as decrease vulnerability for further 
development of these hyperintensities in late-life BP are encouraging (Yuan, Salvadore, 
Li, Zhang, Du, Chen, & Manji, 2009).  
Numerous MRI studies have also identified ventricular enlargement in BP, 
specifically enlargement of the lateral and third ventricles, which researchers have 
viewed as evidence of volumetric reductions of the thalami and/or hypothalami, as the 
lateral ventricle lies above and the third ventricles lie at the medial aspect of the thalami 
(Ferrier, & Thompson 2002; Videbech, 1997; Nasrallah et al., 1982; Pearlson et al., 
1984; Dewan et al., 1988). These findings are consistent with BP symptomatology as the 
thalami are involved in the regulation of arousal and the relaying of information to 
various other parts of the cortex, and the hypothalami are involved in arousal response to 
emotional circumstances and motivated behaviors. However, findings have again been 
inconsistent, with some MRI studies failing to demonstrate ventricular enlargement in BP 
(Johnstone et al., 1989; Swayze et al., 1990; McDonald et al., 1991; Harvey et al., 1994). 
A related research finding that has been largely consistent across studies is that illness-
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episode number is positively correlated with ventricular volumes, which suggests that 
illness chronicity and/or severity may be associated with enlargement of the ventricles in 
BP (Brambilla et al., 2001; Strakowski et al., 2002). 
Functional Imaging 
Due to the technology‟s temporal and spatial resolution abilities, fMRI is currently 
one of the most commonly used neuroimaging modalities in the investigation of 
functional deficits in BP, and studies utilizing this technology have contributed 
significantly to our understanding of the way in which cognitive functioning may differ 
in various phases of BP illness. Numerous studies have found evidence that suggests 
differential right hemispheric impairment during active BP episodes (Bruder, Stewart, 
Towey, Friedman, Tenke, voglmaier, Leite, Cohen, & Quitkin, 1992; Caligiuri, Brown, 
Meloy, Eyler, Kindermann, Frank & Lohr, 2004). In one study, which utilized fMRI to 
examine potential cortical asymmetry in individuals with BP during manic and depressed 
illness phases, researchers found that depressed BP subjects had difficulty suppressing 
right hemispheric activity when engaging in right-handed tasks (Caliguiri et al., 2004).  
In a similar study in which cerebral laterality in BP and unipolar depression was 
compared, evidence was found suggesting right hemispheric dysfunction and left visual 
field accuracy deficits in BP depression. Interestingly, these deficits were not found in 
unipolar depression (Bruder et al., 1992).  
Right hemispheric dysfunction could explain much of the social and emotional 
impairment often experienced by those with BP as various studies have found evidence 
that the right hemisphere may be preferential in the lexical and prosodic aspects of 
emotional auditory information and is more sensitive to the affective semantic content of 
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stimuli. More interesting is the finding of one of these studies of a processing advantage 
for negatively valenced words in currently depressed individuals and in those not 
currently depressed but who have been depressed in the past, whereas never-been-
depressed individuals have a processing advantage for positively valenced words 
(Atchley, Stringer, Mathias, Ilardi, & Minatrea, 2006; Atchley, Ilardi, & Enloe, 2003; 
Bobes, Martin, Olivares, & Valdes-Sosa, 2000).  
Systemic problems involving other neural regions and circuits necessary for normal 
social functioning have also been found. In a recent study in which BP youth (ages 7-18) 
completed an fMRI facial emotion identification task with attention directed to emotional 
(hostility and fearfulness) and nonemotional (nose width) facial features, whole brain 
functional connectivity with the left amygdala was examined. Results of the study 
indicated that the BP subjects had reduced connectivity between the left amygdala and 
the right posterior cingulated-precuneus and right fusiform gyrus/parahippocampal gyrus. 
Reduction in connectivity in the BP subjects was observed independent of mood state or 
comorbid diagnoses (Rich, Fromm, Berghorst, Dickstein, Brotman, Pine, & Leibenluft, 
2008). In that these regions of reduced connectivity have previously been implicated in 
the processing of facial expressions and social stimuli, these are important findings and 
add to mounting evidence of the functional abnormalities that underlie the 
neuropsychological deficits, emotional abnormalities, and psychosocial dysfunction seen 
in BP.  
Other studies in which cortical and subcortical brain regions were investigated during 
active phases of BP illness have also been productive in clarifying the pathophysiology 
of BP.  Studies in which PET and SPECT scan technology were utilized indicate the 
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presence of abnormalities in anterior
 
cingulate function in manic and depressive phases 
of BP (George et al, 1993; Ito et al, 1996).  Manic patients in these studies demonstrated 
increased activity in the left dorsal anterior cingulate cortex, an area vital to important 
cognitive functions, such as the production of empathy, modulation of emotional 
responses, reinforcement, and the anticipation of reward. In contrast, depressed BP 
subjects demonstrated decreased cerebral blood flow in the prefrontal cortex, a region of 
the brain involved in complex cognitive behaviors and higher order functions such as 
impulse inhibition and modulation, moderation of social behavior, mediation of 
conflicting cognitions, problem solving, foresight, short-term memory, set-shifting, 
mental flexibility, and the encoding of unfamiliar faces. Decreased cerebral blood flow 
was also found in depressed BP patient limbic and paralimbic regions, which are 
involved in the production of emotion, interpretation of emotional stimuli, formation of 
emotional associations in memory, and motivation, and nucleus accumbens, which 
receives dopaminergic projections and is involved in reward and reinforcement, the 
experience of pleasure and euphoria, and sexual arousal. These abnormalities are 
consistent with the emotional dysregulation and social dysfunction often seen in BP 
(George et al, 1993; Ito et al, 1996).      
 
Neurochemical Abnormalities 
Several theories regarding the role of neurotransmitters in BP have been asserted over 
the years.  One such theory posits the existence of functional deficits in regard to the 
catecholamine neurotransmitters, specifically a depletion of norepinephrine or dopamine 
at the neuronal synaptic cleft in depressive episodes and an excess of these 
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neurotransmitters in mania (Schildkraut, 1965).  One study investigated the relationship 
between visual tracking, motor speed, and catecholamine system function.  Subjects were 
inpatients in participating centers of the National Institute of Mental Health Clinical 
Research Branch Collaborative Study on the Psychobiology of Depression. Results 
suggested that catecholamine systems may be associated with impairment in 
psychomotor processes as well as an increase in arousal in individuals with BP (Swann, 
Katz, Bowden, Berman, & Stokes, 1999).  
A similar theory implicates the indolamine, serotonin.  Still other theories have 
investigated potential functional deficits in regard to GABA and acetylcholine, which 
would suggest a more generalized neurochemical dysregulation in BP (Redmond & 
Leonard, 1997).  Though neurochemical abnormalities appear to be associated to some 
degree with the dysfunction in BP, studies attempting to validate these theories as major 
etiological factors have failed to garner adequate support.   
 
Neurocognitive Deficits 
A broad range of neuropsychological deficits have repeatedly been shown to be 
associated with BP illness, and many of these deficits are thought to be of greater severity 
and to be manifest differently in BP than in other mood disorders. These deficits found in 
BP include impairment in learning, attention, verbal and visual memory, visuo-spatial 
perception, executive function, processing speed, psychomotor speed, and dexterity.  
(Bearden, Hoffman, & Cannon, 2001; Basso, Neel, Lowery, Purdie, & Bornsein, 2002; 
Wilder-Willis, 2003). 
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Several studies have sought to identify prodromal deficits in BP, and findings of these 
studies have important implications with regard to the identification of populations at 
particular risk for BP and potential benefits of early intervention.  In a study involving 
seven pairs of monozygotic twins discordant for BP, the affected twins displayed deficits 
as compared to their unaffected twins and in relation to normal monozygotic twin 
controls on visual processing measures (which could possibly be due to right hemispheric 
deficits) as well as short- and long-term verbal memory tasks.  On the Test of Facial 
Recognition, the affected twins performed significantly worse than did the unaffected 
twins or the normal controls.  Additionally, on the Continuous Performance Task and on 
several measures of the California Verbal Learning Task (particularly, the short delay, 
cued recall and recognition hits), the affected twins performed more poorly than did their 
unaffected twins and normal controls (Gourovitch, Torrey, Gold, Randolph, Weinberger, 
& Goldberg, 1999).  Cognitive deficits were not found to correlate with most measures of 
symptomatology, which suggests that impairment may be trait-related. Perhaps the most 
interesting finding in this study, however, was that the unaffected twins displayed more 
cognitive impairment on several short-term memory and verbal memory tasks than did 
the normal controls, although impairments were not as extensive as were those found in 
the affected twins.  In another study in which individuals with BP were compared to their 
unaffected first degree family members and healthy controls, the BP group and their first 
degree family members performed significantly worse than controls on measures of 
visuospatial/constructional ability, executive function, and motor function, with the first 
degree relatives performing at an intermediate level between the other two groups 
(Frantom, Allen, & Cross, 2007). 
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Similarly, a retrospective study of premorbid functioning in BP reported the existence 
of various cognitive and motor impairments in individuals that later developed BP, and 
these deficits were found to be more pronounced in those subjects who later experienced 
psychotic features (Sigurdsson, Fombonne, Sayal, & Checkley, 1999).  These findings 
suggest the existence of a genetic link or risk for those with a family history of BP or 
other mood disorder.  This notion is supported by findings of a study in which diminished 
subgenual prefrontal cortical volumes were identified in subjects with a family history of 
mood disorder. These subjects, some of whom had been diagnosed with BP and some of 
whom had no diagnosis, were found to have subgenual prefrontal cortices that were 40% 
smaller than that of NC subjects (Drevets et al, 1997).  In a similar study, researchers 
found 25% reductions in the subgenual prefrontal cortical volumes in first-break 
psychosis patients with a family history of mood disorder (Hirayasu et al., 1999).  
In light of the fact that the number of affective episodes experienced and chronicity of 
illness is positively correlated with impairment severity in BP, these findings have 
obvious important implications. Identification of genetic markers and premorbid deficits 
in BP may help to clarify the pattern of neurocognitive morbidity unique to the disorder, 
enable detection of those at particular risk for illness development, promote accuracy in 
diagnosis, and facilitate efficacy in treatment and interventional considerations (Ferrier & 
Thompson, 2002).  
Depressive Illness Phase 
Various studies have attempted to compare neuropsychological impairment and 
dysfunction in the active phases of BP and the remitted or euthymic states of BP illness.  
One such study, in which cerebral laterality in BP depression and unipolar depression 
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was compared, utilized visual half-field and dichotic listening measures of perceptual 
asymmetry to investigate brain laterality differences between the groups. Findings 
demonstrated that individuals with BP depression had greater impairment than did the 
NC group or those with unipolar depression in identifying left visual field stimuli, but not 
right visual field stimuli. This is an interesting finding in that the unipolar depression and 
NC groups were found to have a left visual field advantage on the measures. This 
difference lends support to the contention of right hemispheric dysfunction in BP.  
Further, the BP subjects in the study exhibited abnormal asymmetry during auditory 
discrimination tasks, which may indicate early sensory and attentional processing deficits 
in BP (Bruder et al, 1992).  Another study in which motor deficits in individuals with 
unipolar depression were compared to those in BP depression reported that although both 
groups demonstrated deficits in motor speed, dexterity, and visual tracking, psychomotor 
dysfunction was related to symptom severity in BP depression but not in unipolar 
depression (Swann et al, 1999).  Additionally, a comprehensive review of the 
neuropsychological and neuroimaging literature on BP reported greater impairment in 
frontal-executive function, attentional processes, and memory function in individuals 
with BP depression than in unipolar depression (Bearden, Hoffman, & Cannon, 2001). A 
recent meta-analysis of the literature regarding neuropsychological dysfunction specific 
to BP found greatest impairment in phonemic fluency in those in the depressed phase of 
illness (Kurtz & Gerraty, 2009).    
Manic Illness Phase 
 
Various studies have also revealed cognitive deficits that unique to the manic phase 
of BP.  In one study in which a discriminant function analysis was utilized, results 
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showed illness phase-specific deficits in sustained attention, verbal learning and memory 
in BP mania (Clark, Iversen, & Goodwin, 2001). In a recent meta-analysis of 
neurocognitive deficits in various phases of BP, research indicated that although 
impairment in verbal learning was found even in euthymic illness states, these deficits 
were exaggerated during manic and mixed illness phases (Kurtz & Gerraty, 2009).    
Euthymic Illness Phase 
Although the etiological specifics of BP illness are still not well understood,  
technological and scientific advances have increased our ability to investigate the 
potential genetic and environmental factors that may contribute to the development of 
BP.  These advances have also enabled us to better understand the pathophysiology of the 
illness and the way in which BP is expressed over various illness phases as well as over 
the lifespan.  
Historically, research focused primarily on the investigation of cognitive deficits 
within active phases of BP, and this myopic research focus hindered advancement of 
understanding regarding illness course. This isolated focus was largely due to the belief 
that BP had a relatively benign course, with euthymia seen as a state of illness recovery 
and those affected by the illness thought to experience little if any persistent cognitive 
deterioration or impairment. More recently, investigation has turned to these euthymic or 
remitted BP states, and converging evidence suggests a chronic illness course, with 
pervasive and persistent cognitive impairment being found across a range of tasks of 
attention, memory, and executive function even in remitted phases (Clark, Iversen, & 
Goodwin, 2002; Tavares, Drevets, & Sahakian, 2003; van Gorp et al., 1998). An added 
benefit of this research is that while gaining insight as whether observed impairments in 
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BP are trait-dependent or state-dependent, the neurobiological disturbances that underpin 
these behavioral deficits are also being identified.    
 One study which investigated neuropsychological deficits in BP euthymic states 
reported impairments in verbal learning and memory as measured by the California 
Verbal Learning Test and the Wisconsin Card Sorting Test. Various recent meta-analyses 
of neuropsychological functioning in euthymic BP have also been conducted. One of 
these studies reported a large effect size with regard to impairment on measures of verbal 
learning and delayed verbal memory as well as on measures of nonverbal memory, and 
small to moderate effect sizes on measures of visuospatial functioning (Kurtz & Gerraty, 
2009).  In another multi-study survey, significant impairment was found in letter and 
category fluency, verbal working memory, immediate and delayed verbal memory, 
auditory attention, set-shifting, sustained visual attention, response inhibition, and 
psychomotor speed in euthymic BP (Robinson et al., 2006). Another review of the 
literature regarding cognitive function in euthymic BP patients reported impairment in 
verbal memory, response inhibition, executive function, working memory, visual 
memory, and sustained visual and auditory attention (Arts et al., 2007). A fourth survey 
of studies of neurocognitive function in euthymic BP found greatest impairment in verbal 
learning and significant impairment in verbal fluency, sustained visual attention and 
memory, auditory attention, and working memory (Bora et al., 2009).  
These studies and literature reviews are consistent in reporting generalized 
neuropsychological impairment in euthymic phases of BP, with particular impairment 
being found in working memory, verbal learning and memory, and executive function 
measures. They are also consistent in reporting a worsening of many of these deficits 
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during active illness states. Although deficits may be more significant and pronounced in 
active mood episodes in BP, it is clear that much of the psychological deficits are trait 
related and cause chronic and persistent dysfunction even in remitted states (van Gorp, 
Altshuler, Dixon, & Theberge, 1999; Martinez, Vieta, Colom, Torrent, Sanchez-Moreno, 
Reinares, Benabarre, Goikolea, Brugue, Daban, & Salamaro, 2004; Wilder-Willis, 2003).   
 
Emotion Processing Deficits 
Research regarding how the processing of emotional information is affected in 
individuals with BP has not been as extensive as has been the investigation of cognitive 
impairments associated with the disorder.  Emotion processing and memory are 
bidirectional systems, and awareness of the interconnected nature of these systems is 
fundamental to understanding how affective disorders are maintained. Cognitive models 
of emotional disturbance in affective disorders generally assert that memories of painful 
or negatively charged affective experiences produce attentional biases for emotional 
information and stimuli in the environment. According to these models, these biases are 
not simply side-effects of affective disorders but play a significant role in the causation, 
morbidity, and maintenance of these illnesses. The contention is that even a slight 
emotional disturbance can increase the salience with which an individual perceives an 
experience, and this emotional saliency can become paired with stimuli present at the 
time of the event in memory. This leads to a cycle in which the individual over-estimates 
the negative emotionality of events based on activated memory stores, which in turn 
produces a greater degree emotional disturbance. According to M. B. Arnold‟s excitatory 
theory (1952), memory provides the basis for emotional appraisal. As incoming sensory 
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stimuli impact the individual, memory pathways that are congruent with the emotional 
salience of the stimuli are activated. This activation in turn triggers emotions consistent 
with the activated memories, thus strengthening the neural pathways and making them 
easier to access in the future. Additionally, a major component of the experience of 
emotion is thought to be the anticipation of the way in which current situations may 
relate to future outcomes. In similar fashion, anticipation can activate congruent neural 
pathways in memory and these memories influence appraisal decisions as to whether 
stimuli should be approached or avoided. The salience of a current emotional experience 
therefore, is thought to be the product of one's appraisal of the event in the context of 
activated memory for similar past events. Memories of painful emotional experiences, 
therefore, may not only serve to negatively alter perception of current emotional events, 
but may also reinforce and enhance negative interpretations of current and future events 
for those with BP (Arnold, 1952; Arnold, 1970).  
Arnold‟s model was supported by a recent study in which sensitivity to facial 
expression of basic emotions was investigated in BP during depressed and manic phases 
of illness. Results of the study demonstrated mood-related biases with regard to 
sensitivity to the facial expressions of happiness and negative affect in general in 
depressed BP subjects (Gray, Venn, Montagne, Murray, Burt, Frigerio, Perrett, & Young, 
2006). Findings of a similar study in which fMRI was utilized to examine the ability of 
euthymic BP subjects to recognize facial emotion also appear to support Arnold‟s model. 
In the study differential responses to fear and disgust were also examined in an effort to 
determine the neural correlates of facial emotion processing. Results indicated that facial 
expressions of fear produced greater neural activation in euthymic BP patients as 
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compared to a NC group, with increased left-sided hippocampal activation in the BP 
group (Malhi, Lagopoulos, Sachdev, Ivanovski, Shnier, & Ketter, 2007). Researchers 
speculate that BP patients may demonstrate more hippocampal activation in the 
identification of facial expressions of fear as a result of a higher degree of active 
engagement resulting from past priming experiences (past traumatic emotional events 
associated with BP illness, etc.). 
Arnold‟s model was also foundational to later cognitive models of emotion. One such 
model proposed by Joseph E. Ledoux  extended Arnold‟s theories and placed more 
emphasis on the neuroanatomy involved in the production of emotion and the role of 
memory in this process Ledoux, 1992; Ledoux, 1993; Ledoux, 1996). An Emotional 
Memory System was proposed by Ledoux in which the amygdala, a cortical structure of 
the limbic region, was identified as the most central structure of this system and 
necessary to the appraisal of the emotional significance and interpretation of incoming 
stimuli. According to Ledoux, the amygdala is also involved in the process of encoding 
and retrieving emotional information in memory by way of thalamic circuitry (Ledoux, 
1996). 
Various studies have investigated the way in which emotional memory and/or biases 
for emotional information may enhance or impair performance on cognitive tasks. In a 
study in which hemispheric lateralization was investigated to determine how it affects the 
processing of words with emotional content in currently or previously depressed 
individuals, subjects with a history of depression demonstrated a bias for words with 
negative emotional content.  Response latencies were shorter and responses were more 
accurate for depressed subjects in the identification of words with negative emotional 
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content as compared to identification of positive target words, and this pattern was the 
opposite of that found in a NC comparison group (Atchley, Ilardi & Enloe, 2003).   
A recent study exclusively examined emotion processing in BP by comparing group 
performance on matching tasks of facial emotion recognition and perception of facial 
identity. Results demonstrated that euthymic BP subjects were significantly impaired in 
their ability to identify various facial emotions as compared to the NC group but had no 
such impairment when asked to identify faces with no requirement of recognition of 
facial emotion (Bozikas, Tonia, Fokas, Karavatos, & Kosmidis, 2006).  A similar study 
investigated gender differences as well as differences between BPI and BPII groups in 
recognition of facial emotion ability. Results demonstrated no gender differences. 
However, a significant group effect was found such that the accuracy performance of BPI 
subjects was significantly impaired whereas performance of BPII subjects was similar to 
that of NC subjects (Derntl, Seidel, Kryspin-Exner, Hasmann, & Dobmeier, 2009).  
In another study in which researchers investigated the neurocognitive processes that 
underlie affective and cognitive empathic abilities in BP, affective empathy (defined as 
“the capacity to experience a vicarious response to another person”) and cognitive 
empathy (defined as “the ability to adopt another‟s psychological perspective”) were 
compared in euthymic BP and NC subjects. Theory of mind (defined as “the ability to 
understand the feelings, intentions, and motivations of others”) and executive function 
was also investigated in these groups. BP subjects demonstrated significant deficits in 
cognitive empathy, theory of mind, and cognitive flexibility measures of executive 
function. In contrast, BP subjects demonstrated increased affective empathy and intact 
planning behavior. Interestingly, deficits in cognitive empathy were correlated with 
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performance on tasks of cognitive flexibility, which is consistent with prefrontal cortical 
dysfunction (Shamay-Tsoory, Harari, Szepsenwol, & Levkovitz, 2007). In another study 
of theory of mind abilities in BP, findings indicated significant impairment in depressed 
and manic BP subjects, but intact functioning in euthymic BP subjects (Kerr, Dunbar, & 
Bentall, 2003). However, in a more recent study, Bora et al. found evidence of 
impairment in advanced theory of mind tasks in remitted phases of BP (Bora, Vahip, 
Gonul, Akdeniz, Alkan, Ogut, & Eryavuz, 2005). 
Another study in which perception of affective prosody (defined as “the nonlexical 
component of speech that can communicate information about the emotional state of 
others”) was investigated in BPI. Results demonstrated impairment in the perception of 
affective prosody in euthymic female BPI subjects, specifically with regard to the 
emotions of fear and surprise (Bozikas, Kosmidis, Tonia, Andreou, Focask, & Karavatos, 
2007). 
These findings are significant for various reasons.  The ability to correctly process 
and interpret emotional responses and accurately read the verbal and facial expressions of 
others is essential for normal functioning and healthy social interaction and reciprocity.  
Such impairment may account for the dysfunctional social and interpersonal behaviors 
often found in BP. Moreover, the fact all subjects in these studies were in remitted phases 
at the time of testing supports the assertion that BP is a chronic and debilitating disorder 
in all phases of illness, even in euthymic states. Several recent studies have confirmed 
this connection between emotion processing deficits and psychosocial dysfunction in BP 
(Malhi, Ivanovski, Hadzi-Pavlovic, Mitchell, Vieta, & Sachdev, 2007). A recent 
neuroimaging study in which mirror neuron activation was investigated in an effort to 
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identify the neural substrates responsible for social cognitive difficulties frequently seen 
in BP supports this contention. In the study, euthymic BP and NC groups underwent 
functional MRI while performing a virtual-reality task of social cognition (which 
incorporated cognitive and emotional dimensions) that simulated real-world social 
situations. During the task, subjects were required to guess possible reasons for the 
emotions expressed by virtual humans while viewing their facial expressions, subsequent 
to observing their verbal/nonverbal emotionally valenced (happy, angry, neutral) facial 
expressions. Results indicated that BP subjects had delayed response latencies and 
corresponding accuracy on emotional conditions of the task as compared to the NC 
group. Imaging showed that the NC group had activation of the right anterior cingulate 
cortex, inferior frontal, and insular cortex (regions thought to underpin empathic 
processes during observation of emotional expressions of others) during emotional 
conditions verses neutral task conditions. BP subjects had reduced activation of mirror 
neuron areas (right inferior frontal, prefrontal, and insula cortices), which are thought to 
be integral in enabling empathic understanding and interpretation of emotion in others, 
mainly during angry and happy conditions as compared to the NC group. These results 
suggest that, even in euthymic states, individuals with BP may have difficulty recruiting 
brain regions normally activated in social interactions, in the interpretation of emotional 
cues integral to understanding the emotional states of others (Kim, Jung, Ku, Kim, Lee, 
Kim, Kim, & Cho, 2009). 
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Bipolar I and Bipolar II Disorder Differences 
Neurobiological Abnormalities 
The amount of research that has been dedicated to the investigation of potential 
neurobiological differences in BPI and BPII has been minimal. In a review of the 
literature, McGrath et al (2004) determined that although genetic data suggest potential 
differences between BPI and BPII populations, the imaging and metabolic studies 
available for review were insufficient to provide support for differences and lacked 
adequate power for conclusive inferences to be made due to the small number of studies 
available.   
In a neuroimaging study of cerebral asymmetry in psychotic mood disorders, BP 
individuals with psychosis demonstrated cerebral lateralization whereas BP individuals 
without psychosis and control subjects did not.  This finding may indicate that right 
hemispheric deficits are more strongly associated with BPI in that the presence of 
psychosis in BP is more commonly found in BPI (Reite, Teale, Rojas, Arciniegas, & 
Sheeder, 1999).   
In another neurioimaging study, regional cerebral blood flow was measured via PET 
scan in individuals with BPII during performance of a serial reaction time task.  While in 
the scanner, four boxes were displayed horizontally on a computer monitor in front of the 
subject.  One box at a time was illuminated, the order of illumination being determined 
by a complex sequence that was changed in the last half of the task.  Participants were 
instructed to press specific keys on the keyboard in correspondence to the light sequence 
as quickly as possible. Cerebral blood flow was analyzed during performance of the task 
in an attempt to measure changes in blood flow associated with perceptual responses to 
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illumination sequences.  Both BPII and NC groups were able to accurately encode 
portions of the motor sequence.  However, the BPII individuals showed activation of 
different brain regions while responding to sequence changes during the task than did NC 
subjects.  Moreover, while the NC group demonstrated typical activation of the right 
superior parietal cortex in response to a novel spatial-motor sequence, the BPII group 
showed reduced activation of this region and demonstrated a wide network of activation, 
including activation of the medial prefrontal cortex and limbic structures, not seen in the 
NC group. In that the task was intentionally designed to be affectively neutral, 
researchers speculate that this limbic activation may be indicative of a limbic hyper-
reactivity in individuals with BPII and may be associated with a dysfunction of processes 
of arousal rather than dysfunction of attentional processes. Specifically, individuals with 
BPII may react to certain stimuli in ways that are congruent with the affective nature of 
their illness experience (Berns, Martin, & Proper, 2002).  Unfortunately this study did not 
compare performance of BPI and BPII groups and thus provides no information as to 
potential differences between these groups. 
Neurocognitive Deficits 
Recent bipolar spectrum theories and similar dimensional models conceptualize BP 
subtypes as homogenous disorders that fall along a continuum of severity. Moving 
toward an accurate conceptualization of BP is vital to understanding etiological factors, 
formulating appropriate diagnostic criteria, and developing effective prophylactic and 
treatment modalities for BP. Despite continuing nosological disagreement and conflicting 
views as to the present illness conceptualization as reflected in current BP diagnostic 
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criteria, surprisingly few studies have focused specifically on differences in 
neuropsychological impairment in BP subtypes.   
One recent study in which BPI and BPII suicide attempters were compared on 
various measures of neuropsychological functioning provides evidence contrary to the 
spectrum conceptualization of BP. In the study, individuals with BPI demonstrated an 
intermediate degree of impairment on measures of working memory, attention, and 
psychomotor functioning in relation to BPII and NC groups.  Additionally, the BPII 
group demonstrated deficits on various measures distinct from those found in the BPI 
group. On a simple reaction time motor task and the Stroop Test of Attention, BPII 
individuals demonstrated significant deficits as compared to the BPI and NC groups.  The 
authors of this study infer from these findings that individuals with BPII may 
demonstrate more global patterns of neuropsychological dysfunction in certain domains 
and that BPI and BPII therefore should be studied as separate and distinct disorders rather 
than homogeneous subtypes (Harkavy-Friedman, Keilp, Grunebaum, Sher, Printz, Burke, 
Mann & Oquendo, 2006).   
Other studies, however, report evidence more supportive of the spectrum model, 
although these studies also provide some evidence of performance pattern differences in 
BPI and BPII neurocognitive profiles, suggesting that there may be elements of BP 
subtypes that are consistent with the spectrum conceptualization as well as elements that 
are supportive of distinct illness differences. One recent study in which euthymic BPI and 
BPII groups were compared on cognitive functioning measures found evidence 
supportive of the spectrum conceptualization with BPI patients demonstrating deficits in 
psychomotor speed, working memory, verbal learning, delayed memory, and executive 
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functioning as compared to a NC group and BPII patients demonstrating dysfunction on a 
subset of measures within each of the domains. BPII subjects demonstrated performance 
deficits on measures of psychomotor speed, working memory, and executive functioning 
as compared to the NC group, but no impairment on measures of verbal learning and 
delayed memory. Additionally, the BP groups did not differ significantly from each other 
on any of the domains tested (Dittmann et al., 2008).  A similar finding was reported in 
another recent study in which BPI and BPII group performance was compared on various 
neuropsychological measures. In the study, the BPI group demonstrated significantly 
greater impairment on measures of verbal memory, psychomotor speed, and executive 
function than did the BPII and NC groups. Both BP groups demonstrated significant 
performance deficits on measures of working memory and psychomotor speed, with the 
BPII group demonstrating an intermediate degree of deficit on measures of psychomotor 
speed as compared to the BPI and NC groups. The groups in this study demonstrated no 
differences in visual memory performance (Hsiao et al., 2009). Yet another study 
comparing BPI and BPII group performance on various neuropsychological measures 
reported significant impairment in the BPI group on measures of memory as compared to 
the BPII and NC groups. Additionally, the BPI group showed significant impairment in 
attention and executive function as compared to the NC group, and the BPII group 
demonstrated impairment on a subset of measures in relation to the BPI and NC groups.  
Overall, 24% of the BPI group in this study demonstrated neurocognitive impairment 
whereas 13% of the BPII group demonstrated impairment (Simonsen et al., 2008). 
Although research investigating neuroanatomical and neuropsychological differences 
among BP subgroups has been limited, the research that has been conducted in this 
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regard has generally supported the existence of differences among the subtypes that 
reflect differences in degree of impairment as opposed to distinct deficit differences. 
These findings most consistently support the spectrum conceptualization of BP illness, 
although more research is warranted in order for conclusive determinations to be made.   
 
Conclusion and Hypotheses 
A large body of literature has been devoted to the study of BP, and in recent years 
numerous studies have validated the existence of neurobiological abnormalities involving 
specific cortical and subcortical brain areas as well as molecular, cellular, and neural 
system abnormalities in individuals with BP illness. Various neuropsychological and 
emotion processing deficits, thought to be phenotypic correlates of neurobiological 
abnormalities, have also been identified, although findings have been inconsistent as to 
specifics of these deficits. Less yet is understood with regard to the way in which 
neurocognitive and emotion processing deficits may differ in BP subtypes even though 
understanding these differences in the pattern and magnitude of deficit among BP 
subtypes is arguably essential to the formulation of an accurate illness conceptualization 
(and therefore, diagnosis and treatment considerations). Differential presentation of 
illness course, phenomenology, and symptomatology in BP subtypes strongly suggests 
the presence of differing neuropsychological deficits.   
With these considerations in mind, the current study investigated the way in which 
neurocognitive and emotion processing deficits differ in BPI and BPII populations by 
comparing performance of the two groups on various standard and experimental 
measures designed to assess abilities in Working Memory, Verbal Learning and Memory, 
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Verbal Fluency, Visual Learning and Memory, Visuoconstruction, Psychomotor, 
Executive Function, Attention, and Emotion Processing domains. Performance between 
these two groups in all domains was compared. Additionally, performance in all domains 
among the BPI group, BPII group, and NC group was compared. The intent of these 
comparisons was to determine whether the combined BP group performance supports 
neuropsychological and emotion processing dysfunction as compared to healthy controls. 
Moreover, an aim of this study was to add to the literature regarding disorder 
conceptualization by determining if pattern of neuropsychological performance in BP is 
subtype specific or consistent with a spectrum conceptualization of illness. 
 It was hypothesized that the three groups would demonstrate significant differences 
in performance in specific neuropsychological and emotion processing domains. It was 
additionally hypothesized that the BPII group would demonstrate an intermediate degree 
of impairment on these measures as compared to the BPI and NC groups, (with the BPI 
group demonstrating the greatest degree of deficit) thus lending support to the spectrum 
conceptualization of BP illness.  Based on the extant literature, the following hypotheses 
were proposed: 
Hypothesis 1 
Significant overall differences among the groups will be found in performance within 
the domains of Working Memory, Verbal Learning and Memory for Non-Emotional 
information, Attention, and Executive Function.  
Hypothesis 2 
Significant overall differences among the groups will be found in performance within 
the domains of Learning and Memory for Visual and Verbal Emotional information.  
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Hypothesis 3 
As compared to the NC and BPI groups, the BPII group will demonstrate an 
intermediate level of performance in all domains assessed, with the best performance 
seen in the NC group and the BPI group demonstrating the worst level of performance 
among the groups.  
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CHAPTER 3 
METHODS 
Participants 
Participants for this study were recruited from the University of Nevada, Las Vegas 
and the community at large and comprised three groups.  These groups consisted of: 
1) Thirty-seven subjects diagnosed with BPI as determined by way of the Structured 
Clinical Interview for DSM-IV (SCID; First, Spitzer, Gibbon, & Williams, 1997) 
will constitute a bipolar disorder I group (BPI Group). 
2) Eighteen subjects diagnosed with BPII as determined by way of the SCID-I will 
constitute a bipolar disorder II group (BPII Group). 
3) Eighteen healthy individuals will constitute a normal control group (NC Group). 
All subjects were between 18 and 65 years of age.  Reasonable attempts were made 
insofar as was possible to have approximately equal representation of gender in this 
study.  All participants were required to provide informed consent and to have English as 
their primary language.  Exclusion criteria for participation included a past or present 
Axis I psychiatric diagnosis (with the exception of BPI or BPII for BP groups), as 
determined by self-report, a past or present history of a chronic medical condition with 
known effects on CNS function, traumatic brain injury or other neurological disorder as 
determined by self report, English as a secondary language as determined by self-report, 
a current or recent (within past six months) diagnosis of a substance use disorder as 
determined by way of the SCID-I, current medication use (within the past week) that has 
known CNS function effects (with the exception of medications prescribed specifically 
for the treatment of BP), and/or a hearing impairment as determined by self report, 
 38 
 
hearing aid use, and a brief screener.  Aside from these general inclusion-exclusion 
criteria, individuals with a first-degree relative who had been diagnosed with BP, MDD, 
or schizophrenia were excluded from the healthy control group. 
 
Measures 
 Following is a description of the individual tests administered to participants in 
this study.  
Screening and diagnostic measures 
The Structured Clinical Interview for DSM-IV 
The Structured Clinical Interview for DSM-IV Axis I Disorders (SCID; First et al., 
1997) is a semi-structured interview for diagnoses of DSM-IV Axis I psychiatric 
disorders.  Administration of the SCID-I is to be conducted only by clinicians that have 
been trained in the DSM-IV diagnostic system (APA, 1994).  This instrument has been 
utilized in the diagnosis of both psychiatric and general medical patients and individuals 
in the community for the purpose of mental health surveys and research.  The inpatient 
version of the SCID-I will be utilized in this study, and all 12 modules will be 
administered, including the screening module.  The screening module is composed of 12 
questions that are used to guide or elicit further administration of subsequent modules.   
Each item is rated on a scale of 1 to 3 (1 = symptom is absent, 2 = sub-threshold 
symptom, or 3 = symptom is present). The SCID-I has demonstrated fair to good 
reliability, achieving Kappa values as high as .98 for some diagnoses.  Too, it has shown 
high validity for the diagnosis of schizophrenia, with good sensitivity (.89), specificity 
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(.96), and agreement (.86) when compared to best estimate diagnoses made by 
psychiatrists on first-admission psychotic patients (Fennig et al., 1994). 
Experience and Symptom measures 
The Positive and Negative Affect Symptoms Scale 
The Positive and Negative Affect Symptoms Scale (PANAS) is a 20-item 
questionnaire that assesses the emotional style used by individuals to cope with life 
events.  Respondents indicate the extent to which the adjective presented in each item is 
representative of their current mood.  Each item is rated on a scale of 1 to 5 (1 = very 
little or not at all, 2 = a little, 3 = moderately, 4 = quite a bit, or 5 = extremely).  The 
PANAS has demonstrated high reliability with studies showing internal consistencies 
using Chronbach‟s α of between .85 and .89.  Correlations between the scales of the 
PANAS and those of other depression and anxiety rating scales were also high and 
significant at the .01 level (Crawford & Henry, 2004). 
Hamilton Depression Rating Scale  
The Hamilton Depression Rating Scale (HAM-D) is a 17-item depression rating scale 
that is administered by a qualified rater.  The HAM-D evaluates depressed mood, 
vegetative and cognitive symptoms of depression, and comorbid anxiety symptoms.  It 
provides ratings on current DSM-IV symptoms of depression, with the exceptions of 
hypersomnia, increased appetite, and concentration/indecision.  The total HAM-D score, 
which provides a reliable indication of depression, can also be used to provide a valuable 
guide to progress.  The HAM-D has exhibited high internal consistency, and support for 
its construct validity was demonstrated by its pattern of correlations with other measures 
of depression, anxiety, and depression-relevant cognition.  Factor analyses of the full 23-
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item and 17-item versions of the HAM-D each yielded 4 factors, which accounted for 
49% and 53% of the variance in participants' responses, respectively (Dozois, 2003).  
These results provide strong support for the HAM-D as a reliable and valid instrument 
for the assessment of depressive severity. 
Young Mania Scale 
The Young Mania Scale (YMS) is an 11-item clinician administered rating scale used 
to determine symptoms of mania.  This scale was administered to bipolar subjects only to 
assess mood state as it is used to assess disease severity in patients already diagnosed 
with mania in bipolar disorder.  The rating of each item on the scale is based on the 
subjective report of the individual‟s condition over the previous forty-eight hours, as well 
as behavioral observations of the clinician.  Each item is rated on a 0 to 4 scale, (absent to 
overtly present) with the exception four items, which receive double weighting and are 
rated from 0 to 8.  This scale was administered by a trained clinician who assigned a 
severity rating for each item based on a personal interview.  The YMS has shown high 
inter-rater reliability by demonstrating a high correlation between scores of 2 
independent clinicians on both total score (0.93) and individual item scores (0.66-0.92).  
Further, the YMS overall score has been shown to be highly correlated with an 
independent global rating and with scores from two other commonly used mania rating 
scales (the Petterson and the Beigel Scales) when the scales were administered 
concurrently. 
Premorbid and Current IQ Estimates 
Vocabulary, Information, and Block Design Subtests 
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The Vocabulary and Information subtests of the Wechsler Adult Intelligence Scale-
3
rd
 Edition (Wechsler, 1997) were used to estimate premorbid IQ.  The Information and 
Vocabulary subtests have the highest reliabilities among the verbal WAIS subtests (.89 
and .96, respectively).  They are considered as “hold” tests and do not change 
considerably over time, even in the presence of brain dysfunction (Vanderploeg, Schinka, 
& Axelrod, 1996).  The mean of the Vocabulary and Information age-corrected scaled 
scores were used as an estimate of premorbid IQ (Bilder et al., 1992).  
A dyadic short form of the WAIS-III scaled scores on the Vocabulary and Block 
Design subtests were used to estimate current IQ.  This score is calculated using 
regression equations that have been normed on a mixed neurological/psychiatric sample 
to estimate the Full Scale IQ score (Ryan, Utley, & Worthen, 2006).   
The Block Design subtest involves nonverbal problem solving skills, spatial 
visualization/organization abilities, sustained attention and visual motor coordination, the 
ability to analyze the whole from constituent parts, and has been found to be sensitive to 
right parietal dysfunction (Groth-Marnat, 1999).  In the Block Design subtest, 
participants are shown a series of red and white spatial designs of increasing difficulty 
via a stimulus booklet.  Participants are asked to duplicate the designs with red and white 
blocks, all of which are identical (2 red sides, 2 white sides, and two sides of half red and 
half white).  This measure is a speeded task in which accuracy and speed of completion 
contribute to overall level of performance.   
Neuropsychological measures 
The neurocognitive tests utilized in this study assessed Working Memory, Verbal 
Learning and Memory, Verbal Fluency, Visual Learning and Memory, 
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Visuoconstruction, Psychomotor, Executive Function, Attention, and Emotion Processing 
abilities. Most of the measures used are widely utilized research instruments and have 
been effectively used on multiple occasions in previous studies attempting to assess 
neuropsychological and emotion processing function in individuals with BP.  
Collectively, these measures served as a comprehensive neuropsychological test battery 
and results therefore are thought to constitute a representative index of cognitive ability 
in the domains assessed.  All measures were administered and scored in the appropriate 
standardized fashion through use of the testing manuals. Psychometric data of all tests 
were available in standard neuropsychological texts (Lezak, 2004). All test scores were 
double checked and double entered by qualified laboratory assistants.  
All participants were administered the same battery of neuropsychological tests and 
received the following measures:   
1) Vocabulary Wechsler Adult Intelligence Scale-III Subtest 
2) Information Wechsler Adult Intelligence Scale-III Subtest 
3) Block Design Wechsler Adult Intelligence Scale-III Subtest  
4) Digit Span Wechsler Adult Intelligence Scale-III Subtest 
5) Spatial Span Wechsler Memory Scale Subtest 
6) The California Verbal Learning Test, Second Edition (CVLT-II)  
7) Controlled Oral Word Association Test  
8) The Biber Figure Learning Test- Expanded (BFLT-E) 
9) Rey-Osterrith Complex Figure (ROCF)  
10) Purdue Pegboard 
11) Grip Strength 
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12) The Trail Making Test A and B  
13) The Wisconsin Card Sorting Task (WCST) 
14) The Stroop Color-Word Association Test 
15) The Emotional Verbal Learning Test (EVLT) 
16) The Facial Affect Learning and Memory Test, Second Edition (FALMT-II) 
Digit Span 
The Digit Span subtest of the Wechsler Adult Intelligence Scale-3
rd
 Edition has a 
forward and a backward component, both of which consist of verbal number pattern 
sequences that are presented to participants in increasing length.  In Digit Span Forward, 
subjects are asked to orally recite these sequences of numbers of increasing length after 
verbal presentation by the examiner.  In Digits Backward, subjects are asked to repeat a 
series of numbers in the reverse order or presentation.  Scores attained for Digit Span 
Forward and Digit Span Backward are combined for an overall total score.  The total raw 
score was used in the analyses as a dependent variable in the assessment of phonological 
loop function. 
Spatial Span  
The Spatial Span Wechsler Memory Scale subtest (Wechsler Memory Scale, 
Wechsler, 1997) has a forward and a backward component, both of which consist of 
spatial pattern sequences that are presented to participants.  In Spatial Span Forward, the 
experimenter points to block sequences of increasing difficulty and length one at a time.  
After each sequence, the participant is asked to point to the same blocks in the same 
sequence.  In Spatial Span Backward, the participant observes the examiner point to a 
series of blocks of increasing length and difficulty but is then asked to point to the blocks 
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in the reverse order of presentation.  A total overall score is derived by adding the Spatial 
Span Forward score to the Spatial Span Backward score.  The Spatial Span total score of 
participants was used as a dependent variable measure of visuospatial sketchpad function 
in this study.  This score was used as it is a visuospatial analog to the Digit Span subtest 
of the WAIS-III. 
The California Verbal Learning Test  
The California Verbal Learning Test, 2
nd
 Edition, Adult Version (CVLT-II) (Delis, 
Kramer, Kaplan, & Ober, 1987) is an instrument designed to test non-emotional verbal 
memory in which the subject is asked to learn a list of 16 common shopping list items on 
5 consecutive trials (learning).  The subject is then asked to recall and recognize these 
items following a delayed interval (memory).  The recall measure involves both cued and 
free recall.  During the CVLT, subjects are told verbally a series of 16 words over five 
immediate-recall trials.  The list consists of 4 words from each of four semantic 
categories (i.e. vegetables, furniture, transportation, and animals).  After this immediate-
recall task subjects are asked to recall the words following a twenty minute waiting 
period in order to measure long term memory.  Therefore, the CVLT measures recall, 
recognition and list learning.  However, interference effects and retrieval/encoding 
difficulties can also be evaluated with this measure. 
 Controlled Oral Word Association Test  
The Controlled Oral Word Association Test, (COWAT; Sumerall, Timmons, James, 
Wing, & Oehlert, 1997) is considered to be a measure of verbal fluency and is also 
believed to secondarily draw on prefrontal or executive function. The measure is 
subdivided into two components: phonetic fluency subtest and a semantic fluency 
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subtest. For the phonetic fluency subtest, participants are required to freely generate as 
many words as possible beginning with a given letter (F, A, and S, respectively) within 
60 seconds (per letter). Proper names or the same words with different endings or 
suffixes are not allowed. For the semantic fluency portion of the test requires semantic 
association and requires participants to freely generate the names of as many examples of 
a given semantic category (names of animals) as possible within 60 seconds. The 
semantic fluency portion of this measure is thought to activate right dorsolateral and 
medial frontal regions of the brain whereas the phonemic fluency portion is thought to 
activate left frontal and temporal regions of the brain (Loring, Meador, & Lee, 1994).  
The Biber Figure Learning Test- Expanded  
The Biber Figure Learning Test- Expanded (BFLT-E) is a modification of the 
original Biber Figure Learning Test, (BFLT; Glosser et al., 1989) and is a test of 
recognition and recall of visuo-spatial stimuli in the form of geometric shapes.  It is 
composed of 15 various geometric designs made up of simple shapes, such as circles, 
triangles, and squares.  These fifteen designs are presented sequentially at a rate of one 
every 3 seconds.  After the designs are presented, participants are asked to draw as many 
of the designs as can be recalled in any order desired.  A task of interference is then 
introduced which is composed of figures different from those included in the 15 original 
design stimuli. This interference task is then followed by an immediate free recall 
condition.  An unrelated task is then administered for 20-30 minutes, after which a 
delayed learning recall trial is introduced wherein verbal, non-visuospatial tasks are 
interjected into the condition.  A recognition task is then introduced in which the 
participant is asked to recognize the original designs which are intermixed with distracter 
items.  The reproduced designs are each scored on a scale of 0 - 3 according to the 
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accuracy of the drawing.  The BLFT-E inter-rater reliability has been found to be very 
good at .98.  It has also demonstrated good test-retest reliability and criterion validity 
(Glosser, Guila, Cole, Lynne, Khatri, & Upama, 2002).  Further, it is sensitive to non-
language-dominant right temporal lobe functioning and visuoconstructional difficulties 
that are related to various types of brain damage or injury, and has been shown to be 
usefulness in the assessment of various components of visuospatial memory in patients 
with lateralized right mesial temporal lobe dysfunction.   
Rey-Osterrith Complex Figure  
The Rey-Osterrieth Complex Figure (ROCF; Rey, 1941; Osterrieth, 1944) is a 
commonly used measure that assesses visual memory and visuoconstructional abilities 
(Lezak, 1995). In the measure, the participant is shown a stimulus card on which a geometric, 
complex figure is depicted. The participant is asked to copy the figure and to subsequently 
reproduce it from memory without warning after a 3-minute delay (delayed recall trial) and a 
30-minute delay (delayed recall trial). Delayed recall is thought to be more sensitive to true 
visual memory deficits than is the immediate recall condition (Loring, 1990). The copy 
portion of the ROCF was used in this study. 
Purdue Pegboard  
The Purdue Pegboard Test (Purdue Research Foundation, 1948) measures gross 
motor coordination and dexterity and psychomotor processing speed. It is sometimes 
used to measure brain lateralization and for localizing cerebral lesions (Spreen & Strauss, 
1998).  The pegboard contains two parallel columns of twenty-five holes in which pegs 
are placed one hand at a time and then with both hands simultaneously under timed 
conditions (30 seconds per trial). Scores for this measure are derived for each trial 
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according to how many pegs were placed within the allotted time limit and a mean score 
is then calculated.  
Grip Strength  
The Grip strength test measures the grip strength of each hand consecutively by way 
of a hand dynamometer. The hand dynamometer is first adjusted to the grip width of the 
participant‟s hand and the participant is then instructed to grip the device with as much 
strength as possible while keeping the arm flush against the side of the body. The mean 
of two trials with each hand is then recorded in kilograms. 
Trail Making Test A and B 
The Trail Making Tests A and B (TMT; Reitan and Wolfson, 1985) were utilized as 
measures of central executive function as they are designed to assess, among other 
things, an individual‟s cognitive set shifting ability.  In Trails A, the participant is asked 
to connect a series of circles containing the numbers from 1 to 25 with a pencil as quickly 
as possible in numerical order.  Similarly, in Trails B, the participant is asked to connect 
circles but to alternate from number to letter, with the circles numbered from 1 to 13 and 
the letters from A to L.   
Parts A and B have a correlation of .49 (Spreen & Strauss, 1998), suggesting that they 
measure somewhat different constructs.  Part B is typically considered to be a more 
complex task, and is thought to be a purer measure of cognitive set shifting and visual 
perceptual processing aspects of working memory than is part A, which is a simpler 
measure visual spanning and psychomotor speed abilities.  The time required (in 
seconds) to complete each part was used as dependent variables. 
 48 
 
The Wisconsin Card Sorting Test 
In the Wisconsin Card Sorting Test, (WCST; Heaton, Chelune, Talley, Kay, & 
Curtiss, 1993) participants are given a pack of 64 cards on which are printed one to four 
symbols (triangle, star, cross, or circle in red, green, yellow, or blue).  Subjects are given 
one card at a time from the deck.  They are asked to place the cards one at a time under a 
set of 4 stimulus cards according to a predetermined principle (color, form, or number), 
which must be deduced by the examinee based on examiner feedback.  The sorting 
principle shifts from color to form, then to number and is thereafter repeated for a second 
set.  Subjects are given corrective feedback with each attempt at sorting in order to 
deduce the sorting principle, but no further directions or prompts are given.  The 
categorization rule shifts after ten successful, consecutive responses, and subjects must 
then decipher the new sorting principle using examiner feedback.  After an additional 10 
correct, consecutive sorts, the sorting principle changes again without warning.  This 
sequence continues until six categories are completed or all of the 128 cards are sorted. 
The Wisconsin Card Sorting test can be administered manually or via compute.  This 
test measures abstract concept formation and the ability to shift cognitive sets as 
feedback is given.  This task has been used extensively in research involving clinical 
populations and has been shown to be sensitive to dorsolateral prefrontal cortex 
dysfunction (Sullivan, Mathalon, Zipursky, Kersteen-Tucker, Knight, & Pfefferbaum, 
1993).  The dependent measures used in this study were perseverative errors, categories 
completed, and failure to maintain set scores of the WCST.   
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The Stroop Color-Word Association Test  
The Stroop Color Word Association Test (Stroop, 1935) is a test of selective 
attention.  This version of the Stroop test consists of three parts in which the participant is 
asked to visually scan words and symbols as quickly as possible for one minute time 
periods.  In the first portion of the task, participants are asked to read color names (a total 
of 100 words) randomly printed in black ink, e.g. blue, red, and green as rapidly as 
possible.  In part two, participants are asked to name the actual color of X‟s printed in the 
three colors (blue, red, and green).  In part three, considered the color-word interference 
task, participants are asked to read the color names while ignoring the color of the printed 
word (which is different than the actual word color).  Although variations of this test 
exist, the most recent version utilizes a time limit of 45 seconds for each section. The 
number of correct items completed in each section is tabulated and an interference score 
is derived in the third section.  The Stroop test is a measure of information processing 
speed as well as ability to focus on task demand.  It is also considered to be a measure of 
ability to rapidly shift attentional set, i.e. suppressing the color of the print while naming 
the word.     
The Emotional Verbal Learning Test  
The Emotional Verbal Learning Test (EVLT; Strauss and Allen, unpublished 
manuscript) is similar to the CVLT in every respect with the exception that the words 
included in the word lists have strong emotional content.  So, rather than words selected 
from semantic categories, word selection was based on emotional content and intensity.  
List A for the EVLT contains 16 words, four from each of the emotional categories of 
happiness, sadness, anger, and anxiety (Strauss & Allen, unpublished manuscript).    
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The Facial Affect Learning and Memory Test- Second Edition  
The Facial Affect Learning and Memory Test- Second Edition (FALMT-II) was 
developed to measure emotional visuo-spatial memory.  During the FALMT-II, subjects 
are shown a series of facial photographs which display a sequence of six different and 
discrete emotions (happiness, surprise, fear, sadness, disgust and anger).  Pictures for the 
task were taken from Penn facial-affect pictures which was developed for the Penn Face 
Memory Test (Gur, Sarab, Hagendoorna, Maroma, Hughetta, Macya, Turnera, Bajcsyb, 
Posnerd, & Gur, 2002) created by Ruben E. Gur at the University of Pennsylvania, 
Neuropsychiatry Section.  In the series, 70 actors and 69 actresses display, via facial 
expression, the emotions of happiness, sadness, anger, fear and disgust.  They also 
display neutral expressions. Each emotion is expressed at three levels of intensity and 
under both posed and evoked conditions. The facial images are of high technical quality 
and have been accurately identified by raters.  This database of emotional expressions 
can therefore be considered as a standard for comparison with clinical populations (Gur 
et al, 2002).  This assessment instrument was loosely modeled after the CVLT-II and 
EVLT in structure in that number of trials is identical and in that it includes a delayed 
recall component for the assessment of long term memory.   
 
Domains of Assessment 
The measures used to assess neuropsychological functioning were grouped broadly 
into 10 neurocognitive domains: 1) Working Memory (Digit Span and Spatial Span 
subtests of the WAIS-III, forward and backward scores), 2) Learning and Memory for 
Verbal Non-Emotional information (CVLT-II trials 1-5), 3)  Learning and Memory for 
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Visual Non-Emotional information (BFLT-E trials 1-5), 4) Attention (Trail Making Test 
A and Stroop Color-Word Association Test congruent and incongruent response times 
and total correct scores), 5) Visuoconstruction ability (Block Design subtest of the 
WAIS-III and ROCF copy trial),  6) Psychomotor ability (Purdue Pegboard and Grip 
Strength dominant and nondominant hand scores), 7) Verbal Fluency (COWAT Animals 
and FAS), 8) Executive Function (Trail Making Test B and WCST perseverated errors 
and failure to maintain set scores) and, 9) Learning and Memory for Verbal Emotional 
information (EVLT trials 1-5), and 10) Learning and Memory for Visual Emotional 
information (FALMT-II trials 1-5).  The measures selected are widely used in both 
clinical and research settings, have been used in previous studies assessing 
neuropsychological functioning in BP and other psychological disorders. These 
assessments were also selected to collectively measure broad domains of cognitive 
functions that would be inclusive in a comprehensive neuropsychological battery. 
 
Apparatus 
For the FALMT-II, all stimuli (in the form of human faces) were displayed via a 
computer screen for 3 seconds per photograph by way of E-Prime software (Psychology 
Software Tools) with a viewing distance of approximately two feet. Verbal response was 
measured by a voice-operated microphone, which was connected to a serial response box 
that relayed the stimulus response interval to E-Prime Data-Aid software (Psychology 
Software Tools, Inc., Version 5.0) on the computer.  The following measures were 
assessed: length of time taken for identification of specific emotions demonstrated in 
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each stimulus, length of time taken for recognition of the various faces used as stimuli, 
and subject accuracy on both measures (Armstrong, 2005). 
The Stroop Color Word Association Test was also presented by way of E-Prime 
software (Psychology Software Tools). Stimuli, in the form of slides, were projected onto 
a computer screen, with a viewing distance of approximately two feet. Verbal responses 
were measured by a voice-operated microphone, which was connected to a serial 
response box that relayed the stimulus response interval to E-Prime Data-Aid software 
(Psychology Software Tools, Inc., Version 5.0) on the computer. Response time for 
recognition of congruent stimuli, response time for recognition of incongruent stimuli, 
and total correct items were assessed. 
 
Procedures 
Subjects were recruited from the community through private mental health 
practitioners interested in involvement in the study, mental health clinics in the 
community with an established relationship with the Department of Psychology at the 
University of Nevada Las Vegas, and various support groups within the community such 
as the National Alliance for the Mentally Ill (NAMI) and the Depression and Bipolar 
Support Alliance of Southern Nevada (DBSA).  An informational flyer, providing 
contact information as well as a brief overview of the study, was posted at various places 
on the University of Nevada, Las Vegas campus as well as at various agencies in the 
community (see Appendix D).  Direct recruiting by way of case managers and mental 
health personnel was also employed in conjunction with participating community mental 
health agencies.  Participants from the University of Nevada, Las Vegas were recruited 
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through the Psychology Department‟s Subject Pool, on-campus mental health service 
providers, and through posted recruitment advertisements placed at various locations.  
UNLV subject pool students received compensation of extra credit points or partial 
fulfillment of their course requirements, equivalent to one credit hour for each hour of 
participation.  Participants who did not complete the entire study were compensated for 
the actual time spent participating.  All other individuals who participated were 
compensated at the rate of $5.00 per hour of participation in the study, with a $30.00 
final compensation given to those who completed the study in its entirety.  Recruiting 
participants in this manner ensured equal participation opportunity in regard to gender 
and ethnicity.     
Upon recruitment, participants completed an informed consent form.  Included in 
Appendix C are all consent forms for a) individuals with BP and healthy individuals 
recruited from the community b) healthy individuals and individuals with BP recruited 
from UNLV.  Prior to participation a trained researcher met individually with each 
participant to explicate the consent form and to ensure understanding of the requirements 
involved in participation.  All potential participants were read the consent form and given 
the opportunity to ask questions.  Two consent forms were signed by the examiner and 
each participant.  One consent form was then given to the participant and one was kept in 
a locked filing cabinet in the Neuropsychology Research Laboratory at UNLV.  This 
process ensured that the privacy of participants will be maintained and that participation 
will be voluntary and under complete informed conditions. All other information 
pertaining to participants will be identified by way of alpha numeric code to ensure 
subject anonymity.  Participants in the study, as will be explicated in the informed 
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consent form, will be given no information or feedback regarding test scores or test 
results.  Raw data will be accessible only to study personnel, including Carol Randall and 
Daniel Allen, as well as research staff as is necessary. 
Following informed consent, all participants were given the same battery of screening 
and diagnostic measures, and neuropsychological tests in a fixed order by the principal 
investigator or a trained research assistant/technician.  All measures and tests were 
administered individually in a quiet, private room at the UNLV Neuropsychological 
Laboratory or at the respective mental health agency if the individual was unable to come 
to UNLV.  The total test administration time was between 6 and 7 hours. 
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CHAPTER 4 
RESULTS 
Data Screening 
Preliminary analyses were conducted prior to performance of the main analyses. Raw 
data from the various neuropsychological tests were inspected to ensure that assumptions 
for multivariate analysis of variance (MANOVA) were met.  Descriptive statistics and 
box plots were carried out for each of the neuropsychological variables, with skewness 
and kurtosis examined to ensure the existence normal distribution of variables and box 
plots utilized to evaluate potential outliers. Outliers were defined as scores lying at least 
3.0 standard deviations above or below the mean, and variables with skewness and 
kurtosis estimates within ± 3.0 were considered to be in the range acceptable for use of 
parametric statistical tests and procedures. In cases where variables were not normally 
distributed, transformations were to be used to increase the normality of the distribution. 
Upon preliminary screening of the data, however, no measures were found to be skewed 
or kurtotic, and no outliers were identified, so MANOVA, repeated-measures analysis of 
variance (ANOVA), and univariate analyses were performed using raw variable scores. 
 
Preliminary Analyses 
Following data screening, preliminary analyses were conducted to determine the 
existence of significant differences among the three groups (BPI, BPII, and NC) on 
variables that are known to have an impact on neurocognitive test performance, including 
age, years of education, premorbid IQ, current IQ, sex, and ethnicity. Differences 
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between the BP groups in global assessment of functioning (GAF score), number of 
psychiatric hospitalizations, and medication status were also examined.  
Likelihood Ratio was utilized for analysis of categorical variable comparisons of the 
three groups, and a binomial test was used for a comparison between the BPI and BPII 
groups on medication status (categorical variable). ANOVA was used for continuous 
variable comparisons among the three groups as well as between the BPI and BPII 
groups, and these analyses were followed by post-hoc contrasts when overall significant 
differences were identified.  The demographic characteristics and results of these 
analyses are presented in Table 1, Appendix A.   
When demographic variables were compared among the BPI, BPII, and NC groups 
(see Table 1), the groups did not differ significantly on age, F(2, 70) = 2.509, p =.089, 
(BPI group: 35.78 ± 14.238 years, BPII group: 31.72 ± 10.764 years, NC group: 27.78 ± 
10.713 years), level of education, F(2, 70) = .168, p =.846, (BPI group: 14.19 ± 2.515 
years, BPII group: 14.56 ± 2.229 years, NC group: 14.39 ± 1.614 years), premorbid IQ 
(which was based on WAIS-III Information and Vocabulary subtest score averages),  
F(2, 70) = 1.088, p = .342, (BPI group: 12.378 ± 2.531, BPII group: 12.000 ± 1.847, NC 
group: 13.056 ± 1.662), or current IQ (which was calculated using the WAIS-III 
Vocabulary and Block Design subtests), F(2, 70) = 1.035, p = .361, (BPI group: 105.460 
± 14.292, BPII group: 104.833 ± 11.848, NC group: 110.333 ± 11.499). The groups were 
found to differ significantly on overall level of functioning, as measured by the Global 
Assessment of Functioning (GAF) scale, F (2, 69) = 17.926, p < .001, (BPI group: 57.53 
± 12.235, BPII group: 67.94 ± 9.200, NC group: 82.17 ± 20.960). For the GAF, post hoc 
analysis indicated that the NC group had significantly higher functioning than the BPII 
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group, who in turn had significantly higher functioning than the BPI group.  When the 
BPI and BPII group GAF scores were compared, results were still significant F (1, 52) = 
10.139, p < .01. 
BPI and BPII groups were then compared on number of mental health 
hospitalizations and current symptom severity (as measured by HAM-D and YMS 
scores). The groups did not differ on number of mental health hospitalizations, F (1, 53) 
= 2.707, p =.106, (BPI group: 2.46 ± 3.141, BPII group: 1.11 ± 2.111) or symptom 
severity, as measured by HAM-D, F (1, 52) = 1.891, p =.175, (BPI group: 8.22 ± 5.623, 
BPII group: 6.18 ± 3.486) and YMS scores, F (1, 53) = .805, p =.374, (BPI group: 4.00 ± 
3.082, BPII group: 3.28 ± 2.081).  
HAM-D and YMRS scores showed that individuals in the BP groups were within the 
euthymic range on average based on the standard cutoff scores of  HAM-D ≤ 8 and 
YMRS ≤ 6  (Hamilton, 1967; Young, Biggs, Ziegler, & Meyer, 1978), and none of the 
participants were experiencing a current mood episode as defined by the SCID at the time 
of testing.  Moreover, given that the mean years of education for the combined BP groups 
was 14.35 years, most were employed and/or attending a University, and the mean 
current IQ for the BP groups was 105.25 (BP groups combined), it is apparent that the BP 
groups were composed of relatively high functioning individuals as opposed to those 
more severely affected by the disorder.   
Likelihood Ratio analyses revealed no significant differences among the BPI, BPII, 
and NC groups on sex, {G (1) = .783, p =.676}, or ethnicity, {G (12) = 16.378, p =.175}. 
BP group comparisons revealed no significant differences between the groups on sex, {G 
(1) = .221, p =.638} or ethnicity, {G (6) = 7.535, p =.274}, and the binomial test 
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comparing medication status (medicated versus un-medicated) between the BPI and BPII 
groups was also non-significant {z = 1.415, p >.05, Confidence Level = 84.3%}. Results 
are displayed in Table 1 (Appendix A).  
Sex distribution within each group was such that the BPI, BII, and NC groups were 
67.60%, 61.10%, and 55.60% female, respectively. With regard to the distribution of 
ethnicity within each group, the BPI group was 67.60% Caucasian, 5.4% Asian 
American, 5.4% Hispanic, 2.70% African American, 2.70% Native American, 8.10% 
Biracial, and 8.10% Other (which category was made up of various less common 
ethnicities). The BPII group was 77.80% Caucasian, 11.10% Asian American, 5.60% 
African American, and 5.60% Native American. The NC group was 44.40% Caucasian, 
22.20% African American, 11.10% Asian American, 11.10% Hispanic, 5.60% Biracial, 
and 5.60% Other. In that the three groups were relatively well matched in terms of these 
demographic variables and no significant differences were found among the groups in 
these demographic variables, sex and ethnicity were not used as covariates in the 
analyses. Results are displayed in Table 1 (Appendix A). 
 
Main Analyses 
After preliminary analyses were completed, Hypothesis one and two were 
investigated. MANOVA was used for analysis of the Working Memory, Verbal Fluency, 
Visuoconstruction, Psychomotor, Executive Function, and Attention domain. Separate 
MANOVA were performed for each domain, and submeasures included Digit Span and 
Spatial Span subtests of the WAIS-III (Forward and Backward trials) for assessment of 
Working Memory, the COWAT (FAS and Animals total scores) for assessment of Verbal 
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Fluency, Block Design (subtest of the WAIS-III) and ROCF (Copy Trial)  for assessment 
of Visuoconstruction abilities, Purdue Pegboard and Grip Strength (Dominant and Non-
dominant Hand scores for each test) for assessment of Psychomotor ability, WCST 
(Perseverated Errors and Failure to Maintain Set) and Trail Making Test B for 
assessment of Executive Function, and Trail Making Test A and Stroop Color-Word 
Association Test (Congruent and Incongruent Response Time and Total Correct Items) 
for assessment of Attention. Combined test scores were used to assess the domains, and 
tests in each domain served as dependent variables in the MANOVA, with group 
membership (BPI, BPII, and NC) serving as the between subjects factor.  When the 
results of MANOVA was found to be significant, univariate ANOVAs and post hoc 
comparisons (Tukey B) were used to examine group differences on individual measures. 
Repeated-measures ANOVA was used to evaluate Learning and Memory domain 
differences among the groups for Non-Emotional and Emotional Visual and Verbal 
information.  In these analyses, the first five learning trials from the CVLT-II, BFLT-E, 
FALMT-II, and EVLT served as the repeated-measures, and group (NC, BPI, and BPII) 
served as the between-subjects variable.  A separate repeated-measures ANOVA was run 
for each of the measures (CVLT-II, BFLT-E, FALMT-II, and EVLT). When the results 
of the repeated-measures ANOVA was significant, univariate ANOVAs and post hoc 
comparisons (Tukey B) were used to examine group differences on the individual 
learning trials. Table 2 (Appendix B) contains descriptive statistics for the domains, 
separate neuropsychological tests, multivariate, repeated-measures, univariate analyses, 
and post-hoc tests. 
 60 
 
Hypothesis three was evaluated by comparing group rankings on domain measures. 
The Kruskal-Wallis Test was first used to obtain group mean rankings on the various 
domain submeasures and then to obtain overall mean rank scores for the three groups for 
all measures combined. Finally, the Mann-Whitney Test was utilized to separately 
compare group rank scores of the BPI and BPII groups as well as between the BPII and 
NC groups (see Table 3).   
 
Analysis of Hypotheses 
Hypothesis One 
 Significant overall differences among the groups will be found in performance 
within the domains of Working Memory, Verbal Learning and Memory for Non-
Emotional information, Attention, and Executive Function.  
Analyses indicated significant performance differences among the groups in four of 
the eight neurocognitive domains, specifically in the domains of Working Memory, 
Visuoconstruction, Attention, and Verbal Learning and Memory for Non-Emotional 
Information, (see Figures 1-4 below).  Expected differences among the groups were not 
present for the Executive Function domain. 
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Figure 1. Working Memory domain by group. 
 
Note: Spatial Span Forward and Backward Trials, Digit Span Forward and  
Backward Trials; Raw Scores = total number correct; BPI = BPI group;  
BPII = BPII group; NC = Normal Control group. 
 
 
 
Figure 2. Visuoconstruction domain by group. 
 
Note: Block Design = Block Design subtest of the WAIS-IV; Rey  
Copy = Rey Osterrith Complex Figure Copy Trial; Raw Scores =  
total number correct; BPI = BPI group; BPII = BPII group; NC =  
Normal Control group. 
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Figure 3. Attention domain by group. 
 
Note. Trails A: Trail Making Test Part A; Stroop Inc RT: Color- 
Word Association Test, Incongruent Response Time; Stroop Con  
RT: Color-Word Association Test, Congruent Response Time;  
Stroop Correct: Color-Word Association Test, Total Number Correct;  
BPI = BPI group; BPII = BPII group; NC = Normal Control group. 
 
Figure 4. Learning and Memory for Verbal Non-Emotional  
Information domain by group. 
 
Note: California Verbal Learning Test – II (CVLT-II), Trial 1, Trial 2, Trial  
3, Trial 4, and Trial 5; Scores = number of words recalled; BPI = BPI  
group; BPII = BPII group; NC = Normal Control group. 
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As predicted, no significant performance differences were found among the groups in 
the Verbal Fluency, Visual Learning and Memory for Non-Emotional information, and 
Psychomotor domains.  
For the Working Memory domain, MANOVA was found to be significant, F (8, 136) 
= 2.191, p =.032, and Tests of Between-Subjects Effects indicated significant differences 
among the groups on Spatial Span Forward, F (2, 70) = 5.574, p =.006, and Spatial Span 
Backward, F (2, 70) = 4.419, p =.016. In the Working Memory Domain, Multiple 
Comparisons revealed significant differences between the BPI and NC groups on Digit 
Span Backward, p =.05, (BPI group: 6.865 ± 2.030, BPII group: 7.611 ± 2.279, NC 
group: 8.444 ± 2.975), Spatial Span Forward, p =.004, (BPI group: 8.297 ± 1.854, BPII 
group: 8.667 ± 1.414, NC group: 10.056 ± 2.182), and Spatial Span Backward, p =.014, 
(BPI group: 7.703 ± 1.942, BPII group: 7.833 ± 1.724, NC group: 9.278 ± 1.994). No 
significant differences were found between the BPI and BPII groups or between the BPII 
and NC groups on any of the submeasures, but group performance fell in the expected 
pattern on Digit Span Backward, Spatial Span Forward, and Spatial Span Backward (see 
Figure 1). 
For the Visuoconstruction domain (see Figure 2), MANOVA was significant, F (4, 
140) = 2.416, p =.05, although no differences were found among the groups on the 
separate measures of the domain, including Block Design, F (2, 70) = 2.036, p =.138, or 
the Copy trial of the ROCF, F (4, 140) = 1.478, p =.235. Moreover, Multiple 
Comparisons indicated no significant differences between the BPI and BPII, the BPI and 
NC groups, or the BPII and NC groups on Block Design, (BPI group: 40.432 ± 14.396, 
BPII group: 43.444 ± 12.641, NC group: 48.167 ± 11.698), and similarly, no significant 
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differences between any of the groups on the ROCF Copy trial were found (BPI group: 
31.122 ± 3.805, BPII group: 29.306 ± 4.983, NC group: 31.194 ± 2.926).  However, 
performance among the groups fell in the predicted pattern on the Block Design test, with 
the NC group performing better than either of the BP groups, and the BPII group 
performing at an intermediate level, between the BPI and NC groups. 
For the Attention domain (see Figure 3), MANOVA was significant, F (8, 136) = 
2.778, p =.007, although Tests of Between-Subjects Effects demonstrated significant 
differences among the groups only on the Stroop Color-Word Association Test, 
Congruent Response Time, F (2, 70) = 3.932, p =.024. Multiple Comparisons revealed 
significant differences between the BPI and BPII groups on the Stroop Color-Word 
Association Test, Congruent Response Time, p =.018, (BPI group: 21728.757 ± 
4333.155, BPII group: 17888.444 ± 5160.706, NC group: 20708.833 ± 5246.317), with 
the BPII performing better than the BPI (as well as the NC group, but not to a significant 
degree). No other significant differences were found between groups in this domain. 
To examine Verbal Learning and Memory for Non-Emotional information, a 
repeated-measures ANOVA was used.  CVLT-II learning trials 1 through 5 were the 
repeated measure, and group served as the between subjects variable.  Results of this 
analysis indicated a significant within subjects effect for CVLT-II learning trial, F (4, 
280) = 205.50, p < .0001, partial eta squared = .746, a significant between subjects effect 
for group, F (2,70) = 7.41, p < .001, partial eta squared = .175, and a non-significant trial 
by group interaction effect, F (8,280) = .51, p = .85, partial eta squared = .014. 
Univariate ANOVAs used to compare performance among the groups on the 
individual trials of the CVLT-II indicated significant differences among the groups for 
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Trial 1, F (2,70) = 5.96, p < .01, Trial 2, F (2,70) = 6.33, p < .01, Trial 3, F (2,70) = 5.41, 
p < .01, Trial 4, F (2,70) = 4.17, p < .05, and Trial 5, F (2,70) = 3.3, p < .05.  Post hoc 
comparisons (Tukey B) indicated that the BPI group performed significantly worse than 
the NC group on all of the learning trials. The BPII group did not differ from the NC 
group or the BPI group on any of the trials, although the performance of the BPII group 
was intermediate to these two groups on all trials (see Figures 4 and 5). 
 
Figure 5. Learning slope by group on CVLT-II. 
 
Note: California Verbal Learning Test – II (CVLT-II), Trial 1, Trial 2, Trial  
3, Trial 4, and Trial 5; Scores = number of words recalled; BPI = BPI  
group; BPII = BPII group; NC = Normal Control group. 
 
Hypothesis Two 
Significant overall differences among the groups will be found in performance within 
the Learning and Memory for Verbal Emotional information and the Learning and 
Memory for Visual Emotional information domains. 
Results of the repeated-measures ANOVA used to examine Learning and Memory 
effects for Emotional Visual information demonstrated a non-significant within-subjects 
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effect on the FALMT-II for trial, F (4, 280) = .42, p = .80, partial eta squared = .006, a 
significant between-subjects effect for group, F (2,70) = 3.52, p < .05, partial eta squared 
= .091, and a significant trial by group interaction effect, F (8,280) = 2.04, p < .05, partial 
eta squared = .055. Univariate ANOVAs used to compare performance among the groups 
on the individual trials of the FALMT-II indicated significant differences among the 
groups for Trial 1, F (2,70) = 6.05, p < .01, Trial 2, F (2,70) = 3.27, p < .05, and Trial 5, 
F (2,70) = 3.56, p < .05.  No significant differences were present for Trial 3, F (2,70) = 
.96, p = .39, and Trial 4, F (2,70) = 1.76, p = .18 (See Figure 6 below). 
 
Figure 6. Learning and Memory for Visual Emotional  
Information domain by group  
 
FALMT = Facial Affect Learning and Memory Test- II, Trial 1, Trial 2,  
Trial 3, Trial 4 and Trial 5. Raw Scores = number of items correctly  
identified; BPI = BPI group; BPII = BPII group; NC = Normal  
Control group.  
 
Post hoc comparisons (Tukey B) indicated that for Trial 1, the BP1 group performed 
significantly worse than the NC and BPII groups.  Tukey B indicated no significant 
differences between groups on Trial 2.  On Trial 5, the BPI group performed significantly 
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worse than the NC group, and the BPII group did not differ from either the NC or the BPI 
group.  As can be seen from Figure 6 above, the significant trial by group interaction 
effect was accounted for by the BPII group doing better than expected on two of the trials 
(Trials 2 and 3). 
Comparable analyses were conducted to examine Learning and Memory for Verbal 
Emotional information (see Figure 7).  EVLT learning trials 1 through 5 were the 
repeated measure, and group served as the between subjects variable. Results indicated a 
significant within subjects effect for EVLT learning trial, F (4, 280) = 145.72, p < .0001, 
partial eta squared = .676, a non-significant between subjects effect for group, F (2,70) = 
7.418, p = .25, partial eta squared = .175, and a non-significant trial by group interaction 
effect, F (8,280) = .67, p = .71, partial eta squared = .019. As can be seen from Figure 6 
below, the significant effect for EVLT Trial resulted from expected improvement in 
performance across the five trials. 
 
Figure 7. Learning and Memory for Verbal Emotional 
Information domain by group. 
 
Note: EVLT: Emotional Verbal Learning Test. Trial 1, Trial 2,  
Trial 3, Trial 4, and Trial 5; Scores = number of words recalled;  
BPI = BPI group; BPII = BPII group; NC = Normal Control group. 
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Hypothesis Three 
As compared to the NC and BPI groups, the BPII group will demonstrate an 
intermediate level of performance in all domains assessed, with the best performance 
seen in the NC group and the BPI group demonstrating the worst level of performance 
among the groups.  
The Kruskal-Wallis Test results indicated a significant overall difference among 
rankings on the combined measures for each group, H(2) = 59.258, p < .001, (BPI group: 
82, BPII group: 67, NC group: 28).  The Mann-Whitney Test comparing mean rank 
scores of the BPI and BPII groups were also significant, U(1) = 521.500, Z = -2.666, p = 
.008, (BPI group: 45.63, BPII group: 33.37), with the BPI group performing significantly 
worse overall than the BPII group. Moreover, the Mann-Whitney Test comparing mean 
rank scores of the BPII and NC groups was significant, U(1) = 209.500, Z = -5.992, p < 
.001, (BPII group: 53.63, NC group: 25.37), with the BPII group performing significantly 
worse than the NC group. Distribution of the rankings by percentage for each of the three 
groups is listed in Table 3, below, and rank scores by group for each of the domains are 
presented in Figures 8-17.  
 
Table 3. Rank percentages by group 
Rank Group 
 NC BPII BPI 
1 71.8% 23.1% 5.1% 
2 25.6% 56.4% 17.9% 
3 2.6% 20.5% 76.9% 
Note. 1= best performance rank score; 2 = intermediate performance rank score; 3 = worst 
performance rank score; NC = Normal Control group; BPII = BPII group; BPI = BPI group. 
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Figure 8. Working Memory domain rank scores by group.  
 
Note. Dig For = Digit Span Forward; Dig Back = Digit Span  
Backward; SpaSp For = Spatial Span Forward; SpaSp Back = Spatial  
Span Backward; NC = Normal Control group; BPII = BPII group;  
BPI = BPI group. 
 
Figure 9. Visuoconstruction domain rank scores by group.  
 
Note. Block Design = Block Design WAIS-III subtest; Rey Copy =  
Rey Osterrith Complex Figure Copy Trial; NC = Normal Control  
group; BPII = BPII group; BPI = BPI group. 
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Figure 10. Attention domain rank scores by group. 
 
Note. Trails A = Trail Making Test Part A; Str Inc RT = Stroop  
Color-Word Association Test Incongruent Response Time; Str Con  
RT = Stroop Color-Word Association Test Congruent Response  
Time; Str Corr = Stroop Color-Word Association Test total correct  
items; NC = Normal Control group; BPII = BPII group; BPI = BPI  
group. 
 
Figure 11. Learning and Memory for Verbal Non-Emotional  
Information domain rank scores by group.  
 
Note. CVLT = California Verbal learning Test- Second Edition  
(Trials 1-5); NC = Normal Control group; BPII = BPII group; BPI =  
BPI group. 
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Figure 12. Executive Function domain rank scores by group. 
 
Note. Trails B = Trail Making Test Part B; WCST PerErr =  
Wisconsin Card Sorting Test, Perseverated Errors; WCST FMS =  
Wisconsin Card Sorting Test, Failure to Maintain Set; NC = Normal  
Control group; BPII = BPII group; BPI = BPI group. 
 
Figure 13. Verbal Fluency domain rank scores by group.  
 
Note. Animals = Animals subtest of the Controlled Oral Word Test;  
FAS = FAS subtest of the Controlled Oral Word Test; NC = Normal  
Control group; BPII = BPII group; BPI = BPI group. 
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Figure 14. Learning and Memory for Visual Non-Emotional  
Information domain rank scores by group.  
 
Note. BFLT = Biber Figure Learning Test- Extended (Trials 1-5);  
NC = Normal Control group; BPII = BPII group; BPI = BPI group. 
 
Figure 15. Psychomotor domain rank scores by group.  
 
Note. Peg DH = Purdue Pegboard dominant hand score; Peg NDH  
= Purdue Pegboard non-dominant hand score; Grip DH = Grip  
Strength test dominant hand score; Grip NDH = Grip Strength test  
non-dominant hand score; NC = Normal Control group; BPII = BPII  
group; BPI = BPI group. 
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Figure 16. Learning and Memory for Visual Emotional  
Information domain rank scores by group. 
 
Note. FALMT = Facial Affect Learning and Memory Test- Second  
Edition (Trials 1-5); NC = Normal Control group; BPII = BPII  
group; BPI = BPI group. 
 
Figure 17. Learning and Memory for Verbal Emotional  
Information domain rank scores by group. 
 
Note. EVLT = Emotional Verbal Learning Test (Trials 1-5); NC =  
Normal Control group; BPII = BPII group; BPI = BPI group. 
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CHAPTER 5 
DISCUSSION 
The existence of neuroanatomical abnormalities, neuropsychological deficits, and 
emotion processing dysfunction in BP has been supported by a growing body of 
empirical evidence, but the outstanding literature has been mixed as to the specifics of 
these deficits and abnormalities. This is not surprising in light of the difficulty in 
accounting for all potential mediating and moderating variables and confounds in such 
investigations, which include medication effects, length and severity of illness, comorbid 
diagnoses, IQ, personality factors, illness insight, environmental factors, psychosocial 
stressors, cultural factors, and more (Yen, Cheng, Huang, Ko, Yen, Chang, & Chen, 
2009; Fleck, Shear, Madore, & Strakowski, 2008). Ecological validity is also often a 
concern in research involving neuropsychological assessment of serious clinical 
populations such as BP. This is true not only in terms of the ecological validity of testing 
in a laboratory setting as opposed to a natural environment, but also with regard to the 
exclusion criteria often utilized in such empirical research. Although excluding subjects 
with comorbid disorders (such as substance use disorders, etc.) may render a “clean” 
sample that is less susceptible to associated confounds, this may nonetheless produce a 
sample that is unrepresentative of the illness as it is found among the general population 
(Pauls, 2004; Michael & Wilhelm, 1996; Sbordone, 1996; Hartman, 1996).  
Despite these challenges, or perhaps because of them, research design and 
methodology have gradually been refined, and innovative approaches have been devised 
to overcome these obstacles and to enable greater validity and reliability of research 
findings.  
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Empirical evidence derived from these sophisticated studies is serving to elucidate 
the pathophysiology of BP, including the way in which the illness is expressed 
neuropsychologically and behaviorally over the lifespan. These studies are also serving to 
increase understanding of the neuroanatomical disturbances that underlie the 
neuropsychological and behavioral illness manifestations seen in BP. Although specific 
findings vary with regard to the pattern and magnitude of deficit found in BP 
populations, some findings have been more consistently supported than others. Those 
neuropsychological deficits that are most consistently identified in studies involving 
euthymic BP populations include disturbances in working memory, verbal learning and 
memory, attention, and executive function processes (Clark, Iversen, & Goodwin, 2002; 
Tavares, Drevets, & Sahakian, 2003; van Gorp et al., 1998; Kurtz & Gerraty, 2009; 
Robinson et al., 2006; Arts et al., 2007; Bora et al., 2009).   
Considering that BP is characterized by emotional lability and dysfunction and the 
mounting evidence in support of neuroanatomical abnormalities and corresponding 
cognitive dysfunction in BP, it is no surprise that evidence of emotion processing deficits 
have also been identified among those with the illness, not only in depressive and manic 
BP phases, but also in euthymic illness states. Emotion processing deficits found in BP 
include impairment in the identification of facial affect, abnormalities in cognitive 
empathy and theory of mind abilities, and deficits in interpreting the affective prosody of 
language (Atchley, Ilardi & Enloe, 2003; Bozikas, Tonia, Fokas, Karavatos, & Kosmidis, 
2006; Shamay-Tsoory, Harari, Szepsenwol, & Levkovitz, 2007; Kerr, Dunbar, & Bentall, 
2003; Bora et al., 2005; Bozikas, Kosmidis, Tonia, Andreou, Focask, & Karavatos, 2007; 
Kim et al., 2009).  
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The ability to accurately interpret the emotional valence and intensity of stimuli in the 
environment and the affective communications of others is critical to normal social 
interaction and functioning. Consequently, it is no wonder that social dysfunction is 
considered to be integral to the functional difficulties commonly realized by those with 
BP (Malhi, Ivanovski, Hadzi-Pavlovic, Mitchell, Vieta, & Sachdev, 2007). 
Although more attention has been focused on deficits in BP over the last several 
years, few studies have investigated the way in which neurocognitive and emotion 
processing deficits may differ among BP subtypes. Findings of those few studies that 
have undertaken this venture generally support quantitative differences or differences in 
magnitude of impairment among BP subtypes (Dittmann et al., 2008; Hsiao et al., 2009; 
Simonsen et al., 2008). Severity differences in emotion processing deficits in BPI and 
BPII populations have also been supported (Derntl, Seidel, Kryspin-Exner, Hasmann, & 
Dobmeier, 2009), with those with BPII typically demonstrating an intermediate degree of 
impairment in relation to those with BPI and NC. Fewer findings support more 
heterogeneous patterns of performance among BP subtypes consistent with a distinct 
disorder conceptualization (as opposed to a spectrum of severity model). 
In consideration of the confirmed existence of differences in phenomenology and 
symptomatology in BPI and BPII populations as well as research findings, albeit small in 
number, that support differential neurocognitive and emotion processing deficits among 
BP subtypes, the aim of this study was to investigate differences in neurocognitive 
functioning and emotion processing abilities in BP populations as compared to healthy 
populations and elucidate potential neurocognitive and emotion processing differences in 
BPI and BPII groups. The findings of this study were intended to add to the extant 
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literature addressing BP illness conceptualization. The hypotheses postulated in this 
study, therefore, were designed to reflect these aims. Research results as they apply to the 
various hypotheses will now be discussed. 
 
Hypothesis One 
Hypothesis one predicted that significant overall differences would be found among 
the groups in performance on measures within the domains of Working Memory, Verbal 
Learning and Memory for Non-Emotional information, Attention, and Executive 
Function. Study results partially supported this hypothesis as significant differences were 
found among the groups in four of the eight domains, including the domains of Working 
Memory, Verbal Learning and Memory for Non-Emotional information, 
Visuoconstruction, and Attention. Executive Function performance was not found to 
differentiate the groups.  
In addition to the overall difference found among the groups in the Working Memory 
domain (see Figure 1), subsequent tests also revealed significant differences on the 
Spatial Span Forward and Spatial Span Backward subtests of the domain. These findings 
are not surprising in that deficits in Working Memory systems are arguably the most 
frequently found neuropsychological deficit in BP populations, even among those in 
euthymic states (Martínez-Arán, Vieta, Reinares, Colom, Torrent, Sánchez-Moreno, 
Benabarre, Goikolea, & Salamero, 2004; El-Badri, Ashton, Moore, Marsh, & Ferrier, 
2001).  However, research findings indicate that the presence of psychosis can underpin 
working memory deficits in BP populations, with some asserting that these deficits may 
be potent trait markers for psychosis in general (Allen, Randall, Bello, Armstrong, 
 78 
 
Frantom, Cross, & Kinney, 2010; Warrick, Wood, Phillips, Francey, Pantelis, Yung, 
Cornblatt, & McGorry, 2006).  In that 50% or more of individuals with BP experience 
psychotic features at some point over the course of illness (Goodwin & Jamison, 1990), 
this is an important consideration.  Interestingly, when psychosis was used as a covariate 
in the Working Memory MANOVA, significance actually increased (p = .006). The 
reason for this is unclear, but this may be an artifact related to the relatively small sample 
sizes utilized in this study. In any case, psychosis does not appear to account for the 
overall differences found in the Working Memory domain in this study.  
An additional consideration is the fact that deficits in working memory are sometimes 
attributable to executive function failures. This is a logical conclusion in that working 
memory is a multi-component, multi-system domain, composed of a subsystem devoted 
to the short-term processing of auditory or phonological information (sometimes referred 
to as the Phonological Loop), a subsystem primarily devoted to the short-term processing 
of visual, spatial, and kinaesthetic information (sometimes referred to as the Visuospatial 
Sketchpad), and a subsystem devoted to planning and recruiting, performance of 
operations necessary for short-term task completion, and integration and allocation of 
incoming information to lower-level processes (sometimes referred to as the Central 
Executive). This last subsystem, the Central Executive, which is primarily devoted to 
executive function processes, overlaps to a considerable degree with general executive 
processes (Baddeley & Hitch, 1974). However, given that no significant differences were 
found among the groups in the Executive Function domain (nor on any of the sub-
measures within this domain), differences among the groups in the Working Memory 
domain are not likely attributable to executive function impairment.  
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Deficits found in the Working Memory domain are also sometimes attributable to 
visual memory impairment. In that two of the subtests within the Working Memory 
domain are visual measures (Spatial Span Forward and Backward subtests of the WMS-
III) and significant differences were found among the groups on these subtests, this is 
another important consideration. However, given that significant differences were also 
found among the groups on the Digit Span Backward subtest of the Working Memory 
domain and that no such differences were found on the BFLT-E, which is specifically a 
visual memory task, Working Memory deficits appear to be supported and independent 
of visual memory impairment.  
Research has identified the frontal cortex, anterior cingulate, and parts of the basal 
ganglia as integral to working memory function (Bledowski, Rahm, & Rowe, 2009; 
Kondo, Osaka, & Osaka, 2004). The anterior cingulate is a brain region thought to play a 
role in a variety of autonomic functions, including blood pressure and heart rate 
regulation, and to various social and cognitive functions such as social reciprocity, 
decision making, anticipation of reward, empathy, and the production of emotion. As 
reviewed previously, multiple studies have identified anterior cingulate grey matter 
reductions in euthymic BP and various anterior cingulate abnormalities in manic and 
depressed phases of BP illness (Drevets et al., 1997; George et al, 1993; Ito et al, 1996). 
Moreover, various studies have found evidence of prefrontal cortex abnormalities in BP, 
including grey matter reductions in the left dorsolateral prefrontal cortex, abnormalities 
of the right dorsolateral prefrontal cortex, and grey matter volume reductions of the 
dorsal, ventral, and orbital prefrontal cortical regions (Haldane & Fangou, 2004; Berns, 
Martin, & Proper, 2002; Brambilla et al., 2002; Lopez-Larson et al., 2002; Frangou et al., 
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2002). The frontal brain regions, primarily the prefrontal cortices, are the highest cortical 
areas of the brain and are responsible for the most complex aspects of cognition, 
including manipulation of sensory information in working memory, the integration of 
sensory and mnemonic information, planning of deliberate action and motor movement, 
and organizational and regulatory aspects of emotional and intellectual functioning.  
Neuroimaging studies have also confirmed abnormalities of the basal ganglia, 
including enlarged putamen in BP (DelBello, Zimmerman, Mills, Getz, & Strakowski, 
2004; Brambilla, Harenski, & Nicoletti, 2001).  The putamen, which is part of the dorsal 
striatum and basal ganglia, draws on dopamine projections to perform its functions in the 
regulation of movements and in influencing certain types of learning. Damage to this 
structure has been shown to cause spatial neglect in humans (Karnath, Himmelbach, & 
Rorden, 2002). 
Given that these various structural and functional abnormalities have been identified 
in BP in areas and processes known to underpin working memory function, as well as the 
fact that mood and affect are known to significantly influence working memory, 
attention, and other cognitive processes, it is no surprise that significant differences were 
found among the groups in this domain. Moreover, in that working memory processes 
involve the temporary storage and management of information utilized in complex 
cognitive tasks, a disruption of working memory processes likely contributes much to the 
dysfunction typically seen in the illness, including executive function deficits. 
Function of the working memory and attentional systems are intricately connected, 
and some theorists view working memory as no more than a combination of short-term 
memory and controlled attention (Kane & Engle, 2003).  Various studies have 
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investigated this overlap between attention and working memory and the way these 
systems interact and contribute to the deficits found in BP. Significant impairment in 
attentional
 
set shifting, sustained attention processes of working memory, and other 
aspects of attention have been found in BP (Clark, Iverson, & Goodwin, 2002), and 
significant overall differences found among the groups in this study in the domain of 
Attention (see Figure 3) is consistent with these previous findings. Tests of between-
subjects effects also revealed significant differences among the groups on the Stroop 
Color-Word Association Test, Congruent Response Time domain sub-measure. This 
finding is somewhat confusing, however. Although accuracy scores have generally been 
found to be similar in BP and NC populations on Stroop tasks, delayed Incongruent 
Response Times have frequently been seen in clinical populations during presentation of 
stimuli with incongruent qualities (Howieson, Lezak, & Loring, 2004). These delayed 
response times in clinical populations during incongruent conditions are thought to be 
due to Stroop effects (extended reaction times when various components of the task are 
incongruent, ex the name of a color is printed in a color not denoted by the name, such as 
the word “green” is printed in red ink) exacerbated by attentional problems associated 
with the illness and difficulty in suppressing incongruent aspects of the stimuli 
(Weissman, Warner, & Woldorff, 2009). Supporting this theory are findings of various 
MRI studies which have indicated altered patterns of cortical activation in BP in brain 
areas known to be critical for execution of complex tasks, sustained attention, and 
inhibition (ex. relative deactivation within the orbital and medial prefrontal brain regions, 
etc.) during Stroop conditions (Kronhaus, Lawrence, Williams, Frangou, Brammer, 
Williams, Andrew, & Phillips, 2006; Gruber, 2002).  
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Given results of these studies and the demands placed on attentional processes in the 
incongruent condition of the Stroop task, a greater difference among the groups was 
expected to be found in Incongruent Response Time than in Congruent Response Time of 
the Stroop Color-Word Association Test. This finding, again, may be a consequence of 
small group size, and further investigation of Stroop effects in BP populations may be 
warranted.   
The finding of an overall difference among the groups in the domain of 
Visuoconstruction abilities was not predicted (see Figure 2), even though some studies 
have found such impairment, not only in BP populations, but also in the first degree 
family members of those with BP.  A case in point are findings of a recent study in which 
BP, first degree family members of BP patients, and normal controls were compared 
across various domains of neuropsychological functioning. Results of this study 
demonstrated significant impairment of both those with BP and the family member group 
in relation to the control group on Block Design and Judgment of Line Orientation tasks. 
Although no significant differences were found between the BP and family member 
group on these measures, the family member group performed at an intermediate level as 
compared to the BP and NC groups (Frantom, Allen, & Cross, 2008). The findings of this 
study suggest that visuoconstructional deficits may be neurocognitive endophenotypes 
for BP. 
Significant differences were predicted among the groups on the Verbal Learning and 
Memory for Non-Emotional information domain, and repeated-measures ANOVA 
indicated a significant between subjects effect for group. Univariate tests revealed 
significant differences among the groups on all learning trials of the domain, and the BPI 
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group performed significantly worse than did the NC group on all trials (see Figure 4). 
Deficits in verbal learning and memory have consistently been reported in studies of BP, 
and some have even found deficits in this domain in the first degree relatives of 
individuals with BP (Arts, Jabben, Krabbendam, & van Os, 2008). However, not all 
studies have been consistent in this finding (Frantom, Allen, & Cross, 2008; Antila, 
Tuulio-Henriksson, Kieseppa, Eerola, Partonen, & Lonnqvist, 2007; Clark, Sarna, & 
Goodwin, 2005). These inconsistencies in the deficits found among BP populations in 
verbal learning and memory may be due to differences among studies in methodological 
approach or sample composition (combining BPI and BPII into one group, including or 
excluding those with psychotic features, etc.) and may not be the result of biological or 
genetic heterogeneity in BP as some have proposed. In that this study specifically 
compared neuropsychological function in well-matched BPI and BPII subtype groups, 
the finding of verbal learning and memory impairment in the BPI group may point to 
verbal memory impairment as an endophenotype specific to BPI. It is also possible that a 
more severely affected BPII sample would demonstrate impairment in this domain as 
well.    
Abnormalities of prefrontal brain regions in BP have been supported in numerous 
studies, and memory research findings have implicated involvement of the left prefrontal 
cortex in the encoding of verbal memory. Specifically, left prefrontal cortical areas are 
thought to mediate verbal information encoding processes that subsequently facilitate 
retrieval of the information from memory (Casasanto, Killgore, Maldjian, Glosser, Alsop, 
Cooke, Grossman, & Detre, 2002; Fernandez et al., 1998, 1999).  
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Verbal learning and memory deficits frequently found in BPI populations may also be 
attributable to the extreme emotional lability and inherently stressful affective states 
associated with this BP subtype. In humans, the hypothalamic pituitary adrenal axis is 
activated in response to stressful emotional events, and glucocorticoid or cortisol (which 
enables the individual to respond to stressors by elevating glucose levels in the brain) is 
consequently released into the system. The hippocampus, which is involved in the 
consolidation (and possibly the retrieval) of new memories, contains glucocorticoid 
receptors, and studies have demonstrated that prolonged stress and release of 
glucocorticoids can serve to modulate memory, although specific findings with regard to 
which memory processes are actually effected (ex. encoding, working memory 
consolidation, retrieval, etc.) have been mixed (Wolf, 2003; Lupien & McEwen, 1997).  
It has been clearly demonstrated, however, that declarative memory is adversely 
affected by chronically elevated cortisol levels, such as is likely the case in BPI (Lupien 
et al., 1998; Martignoni et al., 1992; Wolkowitz, Lupien, Bigler, Levin, & Canick, 2004). 
Findings of studies in which the acute effects of cortisol on memory were investigated 
have been mixed, with some demonstrating impairment of verbal declarative memory 
under such conditions (Kirschbaum, Wolf, May, Wippich, & Hellhammer, 1996; 
Newcomer, Craft, Hershey, Askins, & Bardgett, 1994; Wolf, Schommer, Hellhammer, 
McEwen, & Kirschbaum, 2001; Wolkowitz et al., 1990), some failing to find any effects 
(Hsu, Garside, Massey, & McAllister-Williams, 2003; Wolf, Convit, et al., 2001), and 
others demonstrating opposite findings (Domes, Heinrichs, Reichwald, & Hautzinger, 
2002). These inconsistencies are thought by some to reflect a curvilinear relationship 
between glucocorticoids and verbal memory (Lupien & McEwen, 1997). Others have 
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suggested that stress and cortisol actually facilitate memory consolidation and that 
memory disruption is due to retroactive interference during retrieval processes 
(Roozendaal, 2002).  Animal studies, in which glucocorticoid effects on memory 
consolidation have been isolated, have provided evidence that moderate levels of 
glucocorticoids can provide a facilitative effect to memory processes (Conrad, Lupien, & 
McEwen, 1999; Roozendaal & McGaugh, 1996; Sandi, Loscertales, & Guaza, 1997), and 
several human studies have also found such an effect, particularly with regard to 
consolidation of memory for visual information with and without affective content 
(Buchanan & Lovallo, 2001; Cahill, Gorski, & Le, 2003; Abercrombie, Kalin, Thurow, 
Rosenkranz, & Davidson, 2003).  
However, facilitative effects of stress and cortisol on verbal memory consolidation 
have not been so clearly demonstrated, with one study finding such effects on word recall 
consolidation (Abercrombie et al., 2003) and others finding no facilitative effects 
whatsoever (de Quervain, Roozendaal, Nitsch, McGaugh, & Hock, 2000; Wolf, 
Schommer, Hellhammer, Reischies, & Kirschbaum, 2002) . There is stronger evidence 
that retrieval of verbal memory is adversely affected by stress and elevated cortisol levels 
(Kuhlmann, Piel, & Wolf, 2005). The effect of glucocorticoid and stress on memory, 
therefore, appears to be domain specific.  
The finding of multiple studies that prolonged stress and the release of glucocorticoid 
may facilitate the consolidation of visual memory while impairing retrieval of verbal 
memory is consistent with the findings of this study wherein those with BPI (those 
thought to be most severely impacted by the disorder) were shown to have verbal 
learning and memory deficits but no impairment of visual learning and memory abilities. 
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Moreover, the finding of visuoconstructional deficits in this and other studies is also 
consistent with findings of previous research in which right hemispheric abnormalities in 
BP have been suggested (Bruder, Stewart, Towey, Friedman, Tenke, voglmaier, Leite, 
Cohen, & Quitkin, 1992; Caligiuri, Brown, Meloy, Eyler, Kindermann, Frank & Lohr, 
2004). 
It was expected that overall differences would be found among the groups in the 
Executive Function domain, as the majority of outstanding literature supports deficits in 
this domain  (Bearden, Hoffman, & Cannon, 2001; Basso, Neel, Lowery, Purdie, & 
Bornsein, 2002; Wilder-Willis, 2003; Gourovitch, Torrey, Gold, Randolph, Weinberger, 
& Goldberg, 1999; Clark, Iversen, & Goodwin, 2002; Tavares, Drevets, & Sahakian, 
2003; van Gorp et al., 1998; Kurtz & Gerraty, 2009;  Robinson et al., 2006; Arts et al., 
2007; Bora et al., 2009). The high-functioning nature of the study sample, as evidenced 
by an average of only 2.02 lifetime hospitalizations, mean years of education totaling 
14.31 years, mean current IQ of 105.26, and the fact that most were employed or 
attending the university at the time of testing, may help to explain a lack of significant 
findings.  Additionally, the small size of the groups in this study undoubtedly reduced 
power, and this may be a contributing factor in the failure of executive function measures 
to differentiate among the groups.  
 
Hypothesis Two 
Hypothesis two predicted that significant overall differences among the groups would 
be found in performance within the domains of Learning and Memory for Visual 
Emotional information and Learning and Memory for Verbal Emotional information. 
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Repeated-measures ANOVA results showed that Hypothesis two was partially supported. 
A significant between-subjects effect was found in the domain of Learning and Memory 
for Visual Emotional information, and univariate analyses also showed significant 
differences among the groups on Trial 1, Trial 2, and Trial 5 of the FALMT-II, and post 
hoc tests indicated a that the BPI group performed significantly worse than did the BPII 
and NC groups on the FALMT-II Trial 1 and significantly worse than the NC group on 
Trial 5 of the measure (see Figure 5). An interesting aspect of this finding is that although 
these significant differences were found among/between the groups on performance of 
this measure (FALMT-II), which is a visual memory task with emotional content, no 
such differences were found on the EVLT, which is a verbal memory task with emotional 
content (Verbal Learning and Memory for Verbal Emotional information domain). This 
is the exact opposite of the findings of Hypothesis one in which significant differences 
were found among/between the groups on a verbal memory task without emotional 
content (CVLT-II), but not on a visual memory task without emotional content (BFLT-
E).  
Although this may at first appear to be paradoxical, these findings are likely due to 
the facial component of the FALMT-II test. The processing of facial affect, which is an 
integral aspect of normal social interaction, involves different brain regions than those 
involved in the processing of other visual information with an affective component. As 
discussed previously, various studies have indicated impairment of and reduced 
connectivity between those brain regions known to be integral to the processing of facial 
affect in BP, specifically, reduced connectivity between the left amygdala and the right 
posterior cingulated-precuneus and right fusiform gyrus/parahippocampal gyrus. This 
 88 
 
reduction in connectivity in the BP subjects was observed independent of mood state or 
comorbid diagnoses (Rich, Fromm, Berghorst, Dickstein, Brotman, Pine, & Leibenluft, 
2008). Additionally, deficits in the processing of facial emotion and facial expression 
have repeatedly been demonstrated in Schizophrenia, and some studies have also found 
such deficits in BP (Rich, Fromm, Berghorst, Dickstein, Brotman, Pine, & Leibenluft, 
2008; Gourovitch, Torrey, Gold, Randolph, Weinberger, & Goldberg, 1999; Gray, Venn, 
Montagne, Murray, Burt, Frigerio, Perrett, & Young, 2006). Considering the degree to 
which the identification of facial expression and affect is necessary for normal social 
functioning, these are important findings. 
 
Hypothesis 3 
Hypothesis three predicted that the BPII group would demonstrate an intermediate 
degree of performance impairment in relation to the BPI and NC groups in all domains 
assessed, with the best performance being seen in the NC group and the worst level of 
performance being seen in the BPI group. This hypothesis was found to be supported as a 
significant overall difference was found among group rankings on the combined 
measures. Additionally, performance on a majority of measures (NC = 71.8%, BPII = 
56.4%, BPI = 76.9%) for all groups fell in the expected performance pattern (see Table 
3). Subsequent tests also indicated that BPI group mean-rank scores were significantly 
worse than were the mean rank scores of the BPII group, and the BPII group mean-rank 
scores were similarly found to be significantly worse than the mean-rank scores of the 
NC group.  
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Additionally, although degree of difference and variance is not accounted for in these 
figures, group rank scores fell in the predicted pattern of performance on the Digit Span 
backwards, Spatial Span Forward, and Spatial Span Backward subtests of the Working 
Memory domain (see Figure 7),  the Block Design subtest of the Visuoconstruction 
domain (see Figure 8), the Stroop Color-Word Association Test Total Correct score of 
the Attention domain (see Figure 9), Trials 1-3 of the CVLT-II of the Learning and 
Memory for Verbal Non-Emotional information domain (see Figure 10), Trail Making 
Test Part B of the Executive Function domain (see Figure 11), the Animals subtest of the 
COWAT within theVerbal Fluency domain (see Figure 12), Trials 1-5 of the BFLT-E 
within the Learning and Memory for Visual Non-Emotional information domain (see 
Figure 13), Trials 1, 4, and 5 of the FALMT-II within the Learning and Memory for 
Visual Emotional information domain (see Figure 15), and Trials 2-5 of the EVLT within 
the Learning and Memory for Verbal Emotional information (see Figure 16).   
The predicted pattern of performance on the Animals subtest (a semantic fluency test) 
but not on the FAS subtest (a test of phonemic fluency) of the COWAT within the Verbal 
Fluency domain was an especially interesting finding in that various studies have found 
evidence of impaired semantic fluency and intact phonemic fluency in individuals with 
BP and Schizophrenia, and in older populations (Kremen, Seidman, Faraone, & Tsuang, 
2003; Phillips, James, Crow, & Collinson, 2004). Moreover, various Neuroimaging 
studies of brain activation during fluency tasks indicate that neural activity patterns 
during intact performance on semantic tasks are strongly left lateralized (frontal), 
whereas activity patterns during impaired performance on semantic tasks activate right 
(inferior and middle) frontal brain areas. These findings suggest that efficient recruitment 
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and functional integrity of language areas within the left-frontal brain regions are 
essential for successful performance on semantic fluency tasks (Meinzer, Wilser, Flaisch, 
Eulitz, Rockstroh, Conway, Rothi, & Crosson, 2009). Although the performance of the 
BP groups on the Animals subtest did not reach significance, the pattern of performance 
among the groups, as well as the performance of the BP groups (particularly the BPII 
group) on this measure relative to performance on the FAS subtest is consistent with 
these previous research findings. 
Together, these results generally lend support to the spectrum of severity 
conceptualization of bipolar disorder and the assertion that BPII may be viewed primarily 
as a milder form of the illness than BPI. However, in that a small subset of measures 
indicated a distinct pattern of performance for the two groups (Psychomotor and 
Attention domain subtests, Rey Osterrith Complex Figure Copy Trial of the 
Visuoconstruction domain, etc.), there does appear to be some support for the idea that in 
some aspects of neuropsychological functioning, the subtypes are heterogeneous, 
although these particularly findings may be due to small sample sizes and the high-
functioning nature of the groups in this study. 
Considering this high-functioning nature of the clinical samples used, these 
findings have particularly important implications as it is logical to assume that these 
samples would perform at a level that more closely matches performance of the healthy 
population than would a sample more severely affected by the disorder, and yet 
significant differences were found and the postulated hypotheses of the study were 
largely confirmed. These findings add to the extant literature in the identification of 
neurocognitive and emotion processing deficits specific to BP and lend important 
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information to the ongoing debate regarding the nosological status of BP and the other 
affective disorders. 
 
Limitations 
A limitation of this study is that it is unknown if results were affected by the 
prescribed medications taken by BP subjects. The majority of participants in the BP 
groups were taking prescribed medications at the time of testing, and these medications 
included mood stabilizers (including anticonvulsants), antidepressants, antipsychotics, 
anxiolytics and stimulants, so a rigorous evaluation of the impact medications may have 
had on neuropsychological test performance was not possible. BP groups did not differ, 
however, with regard to medicated verses non-medicated status. Additionally, various 
studies in which medication effects on neurocognitive function in affective and psychotic 
disorders were assessed indicate that some medications may serve a neuroprotective 
function in these disorders (Moore et al., 2000; Sassi et al., 2002; Manji et al., 1999; 
Brambilla et al., 2001; Nugent, Milham, & Bain, 2006). Additionally, normalization of 
neurocognition and brain function resulting from medication treatments have been 
demonstrated in schizophrenia (Keefe et al., 2007; Wittorf, Sickinger, Wiedemann, & 
Klingberg, 2008), major depressive disorder (Fales et al., 2009), and bipolar disorder 
(Gruber et al., 2004; Phillips, Travis, Fagiolini, & Kupfer, 2008), although there is 
contradictory evidence in this regard, particularly in bipolar disorder (Savitz, 2005). 
Given that neurocognitive deficits do persist even in medication-free states in BP and 
schizophrenia (Goswami et al., 2001), it is likely that some neurocognitive deficits are 
genetically driven trait markers that represent functional changes in neural networks in 
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the disorders (Burdick et al., 2007; Savitz et al., 2005). Consequently, it is unlikely that 
medication effects can account for the neurocognitive and emotion processing deficits 
reported in this and other studies. 
Another limitation of this study is that the sample may not representative of the “real 
world” BP populations (as previously mentioned), which typically demonstrate high 
substance use and other psychiatric disorder comorbidity rates. None of the participants 
in the BP groups in the current study had a current comorbid substance use or major 
psychiatric disorder diagnosis. This is another indicator that the clinical groups in this 
study were high-functioning groups overall. Future studies with samples that are more 
representative of those with bipolar disorder in the general population may be warranted 
in the identification of neurocognitive profiles specific to the illness and illness subtypes. 
A third limitation of this study is that the sample sizes of the groups were relatively 
small. Finding BP subjects, particularly those who are outpatient, is a difficult venture 
from the outset, and the exclusion criteria for clinical groups in this study (which 
included comorbid psychiatric and substance use disorders) made this task all the more 
difficult. Moreover, finding BPII subjects is particularly challenging due to an unusually 
high rate of misdiagnosis of the subtype, as well as the fact that many individuals with 
BPII find the hypomanic states of the illness to be egosyntonic, which sometimes inhibits 
treatment seeking behaviors wherein diagnoses are typically made.  
Despite these limitations, the investigation of neurocognitive deficits among BP 
populations, and particularly the way in which these deficits may differ in BP subtypes is 
a venture worthy of pursuit. This is especially true given the ongoing professional 
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disagreement in the field regarding the nosological status of the affective disorders and 
the limited effectiveness of current treatments for these disorders. 
 
Implications and Future Directions 
Bipolar disorder is a debilitating disorder characterized by disruption of various 
symptom domains, including psychosocial dysfunction, emotional lability/affective 
instability, and neurocognitive disruption. It is unclear as to whether the deficits found in 
the BP groups in this study indicate a unique pattern of neurobiological dysfunction, but 
these results add to the mounting literature supporting the existence of such deficits. This 
is important in that deficits in neurocognitive function have been shown to be associated 
with poorer functional outcomes in various psychiatric conditions, including 
schizophrenia (Brekke et al., 2005; Green et al., 2004).  
Additionally, despite a growing body of research dedicated to BP and its subtypes, it 
remains unclear as to whether the subtypes subsumed under this diagnosis are 
representative of a spectrum of severity or whether they would better be conceptualized 
as discrete disorders. The results of this study lend support to the spectrum of severity 
conceptualization model. The argument can be made that the pattern of performance seen 
among the groups on many of the measures in this study, namely the BPI group 
demonstrating the greatest degree of impairment and those with BPII demonstrating a 
less severe degree of deficit (as evidenced by an intermediate level of performance 
between BPI and NC groups), may not be representative of the general “real world” BP 
population. Moreover, inconsistencies across studies with regard to deficits in BP and BP 
subtypes, and those encountered in this study, may actually indicate a lack of validity for 
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the BPII diagnosis itself. Nonetheless, in that the BP groups were particularly high-
functioning, these results are likely an underestimate of true BP deficits and pattern of 
performance among subtypes. An important direction for further evaluation will be to 
investigate whether the pattern of neurocognitive deficits correspond to functional 
outcomes in BP populations. There is some evidence to support this assertion (Bello et 
al., 2008; Martínez-Arán et al., 2007).  
Although the literature on neuropsychological deficits in BP has provided important 
insights regarding the pattern and magnitude of deficit in individuals with the illness, 
much is still unknown or unclear, particularly with regard to the way in which deficits 
may differ among BP subtypes. Early detection, accurate diagnosis, and the development 
of more effective treatment interventions would likely serve to attenuate the cognitive 
morbidity and functional impairment often realized in BP and other affective disorders.  
The identification of a unique profile for BP and BP subtypes, in which these findings are 
taken fully into account, could be beneficial to future psychotherapeutic and 
psychopharmacological approaches to treatment.  Additionally, given the division in the 
literature with regard to the nosological status of the affective disorders and the continued 
lack of consensus as to the diagnostic criteria for BP and its subtypes, future research 
would do well to further this investigation. 
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APPENDIX A 
TABLES 
Table 1. Descriptive statistics and results of comparisons among groups on demographic and clinical variables 
Variable 
Group   
BPI (n = 37) BPII (n = 18) NC (n = 18)   
Mean SD Mean SD Mean SD F(2,70
) 
p 
Age (years) 35.78 14.24 31.72 10.76 27.78 10.71 2.51 0.089 
Education (years) 14.39 2.52 14.56 2.23 14.39 1.61 0.17 0.846 
Premorbid IQ 12.38 2.53 12.00 1.85 13.06 1.66 1.09 0.342 
Current IQ 105.46 14.29 104.83 11.85 110.33 11.50 1.04 0.361 
       F(1,54
) 
p 
GAF Score 57.53 12.24 67.94 9.20   10.14 <.01 
Hospitalizations 2.46 3.14 1.11 2.11   2.71 0.106 
HAM-D 8.22 5.62 6.18 3.49   1.89 0.175 
YMRS 4.00 3.08 3.28 2.08   0.81 0.374 
    G p 
Female (%) 67.60 61.10 55.60 0.77 0.680 
Ethnicity (%)    13.95 0.304 
 Caucasian 67.60 77.80 44.40   
 African Amer 2.70 5.60 22.20   
 Hispanic 5.40 0.00 11.10   
 Asian Amer 5.40 11.10 11.10   
 Native Amer 2.70 5.60 0.00   
 Biracial 8.10 0.00 5.60   
 Other 8.10 0.00 5.60   
     z CL 
Medications (%)       1.415 84.3% 
 Unmedicated 16.20 3.89     
 Antidepress 48.60 50.00     
 Mood Stab       
  Anticonvuls 62.20 33.30     
  Other 5.40 0.00     
 Antipsychotics 48.60 11.10     
 Anxiolytics 29.70 22.20     
 Stimulants 8.10 5.60     
        Note: BPI = Bipolar I group; BPII = Bipolar II group; NC = Normal Control group; SD = Standard  
Deviation; GAF = Global Assessment of Functioning; HAM-D = Hamilton Depression Rating Scale;  
YMRS = Young Mania Scale; Amer = American; Antidepress = Antidepressants; Mood Stab = Mood  
Stabilizers; G = Tukey B; z = z Test for Two Proportions; CL = Confidence Level 
 
 96 
 
Table 2. Neurocognitive domains and measures for bipolar I (BPI), bipolar II (BPII), and normal control (NC) groups. 
Score BPI (n=37) BPII (n=18) NC (n=18) 
  
 
Mean SD Mean SD Mean SD F (df) p Contrasts 
Work Memory 
      
2.191 (8,136) < .05 
 
Digit Span 
          
For 10.541 2.567 11.167 2.333 10.944 2.287 0.442 
   
Back 6.865 2.030 7.611 2.279 8.444 2.975 2.797 
  
BPI < NC 
Spa Span 
          
For 8.297 1.854 8.667 1.414 10.056 2.182 5.574 (2,70) < .01 BPI < NC 
Back 7.703 1.942 7.833 1.724 9.278 1.994 4.419 (2,70) < .05 BPI < NC 
           
Verb Memory 
          
CVLT 
      
7.410 (2,70) <.001 
 
Trial 1 7.108 1.807 8.167 1.948 8.722 1.227 5.960 (2,70) < .01 BPI < NC 
Trial 2 10.081 2.373 11.667 1.847 11.944 1.589 6.330 (2,70) < .01 BPI < NC 
Trial 3 11.784 2.720 12.944 1.924 13.944 1.798 5.410 (2,70) < .01 BPI < NC 
Trial 4 12.676 2.484 13.500 1.978 14.444 1.464 4.170 (2,70) < .05 BPI < NC 
Trial 5 12.973 2.267 13.889 1.779 14.444 1.504 3.300 (2,70) < .05 BPI < NC 
           
Visuoconstruct 
      
2.416 (4,140) 0.05 
 
Block Des 40.432 14.396 43.444 12.641 48.167 11.698 2.036 
   
Rey Copy 31.122 3.805 29.306 4.983 31.194 2.926 1.478 
   
           
Attention 
      
2.778 (8,136) < .01 
 
STROOP 
          
In RT 22820 4874 20753 7525 20393 4037 2 
   
Con RT 21728 4333 17888 5160 20708 5246 4 (2,70) < .05 BPI < BPII 
Tot Corr 77.514 3.124 76.444 3.974 76.889 2.374 0.727 
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TMT A 26.162 9.203 27.278 5.819 22.778 5.429 1.745 
   
           
Exec Function 
      
1.077 (6,138) 
  
WCST 
          
PErrors 13.622 10.644 13.111 9.139 10.167 7.965 0.797 
   
FMS 0.973 1.258 0.889 0.900 0.389 0.778 1.852 
   
TMT B 60.487 27.284 54.111 15.277 49.222 13.401 1.692 
   
           
Psychomotor 
      
0.827 (10,134) 
  
Purdue Peg 
          
DH 13.440 2.732 14.868 2.116 14.166 1.773 2.251 
   
NDH 12.855 2.410 13.756 2.032 13.518 2.145 1.143 
   
Grip Str 
          
DH 31.946 14.642 35.778 11.383 32.917 16.020 0.438 
   
NDH 26.973 13.215 29.528 10.658 29.000 15.504 0.280 
   
           
Verb Fluency 
      
1.276 (4,140) 
  
FAS 44.649 11.046 40.944 10.468 46.222 10.947 1.146 
   
Animals 21.946 5.055 22.722 4.775 24.389 4.996 1.461 
   
           
Vis Memory 
          
BFLT-E 
      
0.673 8,136 
  
Trial 1 6.432 2.167 6.722 2.244 7.667 1.970 2.032 
   
Trial 2 9.757 2.842 10.278 2.321 11.111 1.844 
    
Trial 3 11.351 2.879 11.833 2.407 12.389 2.253 
    
Trial 4 12.189 2.413 12.556 1.917 13.611 1.685 
    
Trial 5 13.000 2.000 13.278 2.109 13.889 1.323 1.343 
   
           
Emo Process 
          
Visual 
          
FALMT 
       
(2,70) <.05 
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Trial 1 10.946 2.934 12.833 2.256 13.167 1.791 6.053 (2,70) < .01 BPI<BPII, NC 
Trial 2 11.351 2.983 13.111 2.026 12.722 2.469 
 
(2,70) <.05 
 
Trial 3 11.919 2.803 12.833 2.595 12.611 1.720 
    
Trial 4 12.081 3.031 12.278 2.986 13.556 1.917 
    
Trial 5 11.676 2.719 12.389 2.852 13.611 1.577 3.561 (2,70) < .05 BPI<NC 
Verbal 
          
EVLT 
          
Trial 1 6.838 1.555 7.444 1.580 6.944 1.626 0.917 
   
Trial 2 8.865 2.030 10.222 1.768 9.778 1.865 
    
Trial 3 10.432 2.433 11.056 1.474 10.833 2.007 
    
Trial 4 10.811 2.343 11.667 2.029 11.389 2.279 
    
Trial 5 11.460 2.468 12.111 2.166 11.556 1.947 0.513 
   
Note. BPI = Bipolar I group; BPII = Bipolar II group; NC = Normal Control group; SD = Standard Deviation; Work Memory = Working Memory domain; Digit Spa = Digit Span WAIS-III 
subtest; For = Forward; Back = Backward; Spa Span = Spatial Span WAIS-III subtest; Verb Memory = Learning and Memory for Verbal Non-Emotional information domain; CVLT = 
California Verbal Learning Test- Second Edition; Visuoconstruct = Visuoconstruction domain; Block Des = Block Design WAIS-III subtest; Rey Copy = Rey Osterrith Complex Figure Copy 
Trial; Stroop = Stroop Color-Word Association Test; In RT = Incongruent Response Time total; Con RT = Congruent Response Time total; Tot Corr = Total Correct; TMT A = Trail Making 
Test Part A; Exec Function = Executive Function domain; WCST = Wisconsin Card Sorting Test; PErrors = Perseverated Errors; FMT = Failure to Maintain Set; TMT B = Trail Making Test 
Part B; Purdue Peg = Purdue Pegboard Test; DH = Dominant Hand; NDH = Nondominant Hand; Grip Str = Grip Strength; Vis Memory = Learning and Memory for Visual Non-Emotional 
information domain; BFLT = Biber Figure Learning Test, Expanded Edition; Emo Process =  Emotion Processing domain; Visual = Learning and memory for Visual Emotional information 
domain; FALMT-II = Facial Affect Learning and Memory Test – Second Edition; Verbal = Learning and Memory for Verbal Emotional information domain; EVLT = Emotional Verbal 
Learning Test;  
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APPENDIX B 
RESEARCH FORMS 
UNIVERSITY OF NEVADA, LAS VEGAS   
INFORMED CONSENT FORM 
 
 
Introduction:  Carol Randall and Daniel Allen, Ph.D., from the Department of 
Psychology at UNLV, are seeking participants for a study that examines the processing 
of emotion in individuals with bipolar disorder. You are invited to participate in this 
research study.   
 
Procedure:  If you volunteer to participate in this study, you will be interviewed and then 
be administered tasks that are designed to test emotion processing and various other 
cognitive abilities.  For these tasks, you will be asked to complete a number of different 
exercises such as remembering lists of words and naming pictures.  During the 
interview, the examiner will ask you general questions such as your age and years of 
education, along with questions regarding your medical history.  At the beginning of the 
study, you will be provided with instructions that will tell you how to complete the tests. 
The total time needed to complete this research project is approximately 6.0 hours, 
although it may take less time for you to complete the study. 
  
Benefits of Participation:  By participating in this study, you will gain a research 
participation credit for every hour of research participation. Participation time in this 
study is expected to be approximately ?credits.   
 
Risks of Participation:  There is a chance you may experience some mental fatigue 
during the assessments.  To decrease the chance of fatigue, the researcher will allow 
breaks as necessary for your comfort.  Although it is not expected to occur, should you 
feel uncomfortable answering any of the questions or performing any of the tasks, you 
are encouraged to discuss concerns with the researcher.  Your participation is voluntary 
and you may refuse to answer questions or withdraw from the study at any time. 
 
Contact Information: If you have questions about the study, or if you experience any 
harmful effects because of participation in this study, you are encouraged to contact 
Carol Randall or Daniel Allen at 895-0295. 
 
For questions regarding the rights of research subjects, you may contact the UNLV 
Office for the Protection of Research Subjects at 895-2794.  
 
Voluntary Participation:  Your participation in this study is voluntary. You may refuse to 
participate in this study or in any part of this study.  You may withdraw at any time 
without prejudice to your relations with the university. You are encouraged to ask 
questions about this study at the beginning or any time during the research study.  
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Confidentiality:  All information gathered in this study will be kept completely 
confidential.  No reference will be made in written or oral materials that could link you to 
this study.  All records will be stored in a locked facility at UNLV for at least 3 years after 
completion of the study.  After this three-year period, all test materials will be destroyed. 
 
 
 
Participant Consent:  
 
I have read or have had read to me all of the above information.  I have had all of 
my questions answered and understand the purpose, procedures, risks and benefits 
of the study.  I agree to participate in this study.  I certify that I am at least 18 years 
of age.  A copy of this form has been given to me. 
 
 
 
 
 
 
 
______________________________________                    ___________________ 
Name        Date 
 
 
_____________________________________                     ___________________ 
Signature                  Date                                                           
Witness 
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COMMUNITY OF LAS VEGAS, NEVADA 
INFORMED CONSENT FORM 
 
 
Introduction:  Carol Randall and Daniel Allen, Ph.D., from the Department of 
Psychology at UNLV, are seeking participants for a study that examines the processing 
of emotion in individuals with bipolar disorder. You are invited to participate in this 
research study.   
 
Procedure:  If you volunteer to participate in this study, you will be interviewed and then 
be administered tasks that are designed to test emotion processing and various other 
cognitive abilities.  For these tasks, you will be asked to complete a number of different 
exercises such as remembering lists of words and naming pictures.  During the 
interview, the examiner will ask you general questions such as your age and years of 
education, along with questions regarding your medical history.  At the beginning of the 
study, you will be provided with instructions that will tell you how to complete the tests. 
The total time needed to complete this research project is approximately 6.0 hours, 
although it may take less time for you to complete the study. 
  
Benefits of Participation:  By participating in this study, you will receive $5.00 per hour 
of participation in the study, with a $30.00 final compensation given upon completion of 
the study in its entirety.   
 
Risks of Participation:  There is a chance you may experience some mental fatigue 
during the assessments.  To decrease the chance of fatigue, the researcher will allow 
breaks as necessary for your comfort.  Although it is not expected to occur, should you 
feel uncomfortable answering any of the questions or performing any of the tasks, you 
are encouraged to discuss concerns with the researcher.  Your participation is voluntary 
and you may refuse to answer questions or withdraw from the study at any time. 
 
Contact Information: If you have questions about the study, or if you experience any 
harmful effects because of participation in this study, you are encouraged to contact 
Carol Randall or Daniel Allen at 895-0295. 
 
For questions regarding the rights of research subjects, you may contact the UNLV 
Office for the Protection of Research Subjects at 895-2794.  
 
Voluntary Participation:  Your participation in this study is voluntary. You may refuse to 
participate in this study or in any part of this study.  You may withdraw at any time 
without prejudice to your relations with the university. You are encouraged to ask 
questions about this study at the beginning or any time during the research study.  
 
Confidentiality:  All information gathered in this study will be kept completely 
confidential.  No reference will be made in written or oral materials that could link you to 
this study.  All records will be stored in a locked facility at UNLV for at least 3 years after 
completion of the study.  After this three-year period, all test materials will be destroyed. 
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Participant Consent:  
 
I have read or have had read to me all of the above information.  I have had all of 
my questions answered and understand the purpose, procedures, risks and benefits 
of the study.  I agree to participate in this study.  I certify that I am at least 18 years 
of age.  A copy of this form has been given to me. 
 
 
 
 
 
 
 
______________________________________                    ___________________ 
Name        Date 
 
 
_____________________________________                     ___________________ 
Signature                  Date                                                           
Witness 
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APPENDIX C 
IRB APPROVAL FORMS 
 
 
 
 
 
Social/Behavioral IRB – Expedited Review 
Modification Approved 
 
NOTICE TO ALL RESEARCHERS: 
Please be aware that a protocol violation (e.g., failure to submit a  modification for 
any change) of an IRB approved protocol may result in mandatory remedial 
education, additional audits, re-consenting subjects, researcher probation suspension 
of any research protocol at issue, suspension of additional existing research 
protocols, invalidation of all research conducted under the research protocol at 
issue, and further appropriate consequences as determined by the IRB and the 
Institutional Officer. 
 
 
DATE:  November 9, 2006 
 
TO:  Dr. Daniel Allen, Psychology 
 
FROM: Office for the Protection of Research Subjects 
   
RE:  Notification of IRB Action by Dr. J. Michael Stitt, Chair 
Protocol Title: Neuropsychological and Emotion Processing Deficits in Adults with 
Bipolar Disorder 
Protocol #: 0510-1779 
 
The modification of the protocol named above has been reviewed and approved. 
 
Modifications reviewed for this action include: 
 The title of the study will change to "Neuropsychological, Emotional, and Functional Deficits in 
Adults with Bipolar Disorder. 
 The addition of Daniell Knatz, Carol Randall, and Brian Leany to the research team. 
 The addition of Mojave Adult, Child and Family Services to the research sites. 
 The expected amount of completion time will change to 6 hours. 
 The removal of the Minnesota Multiphasic Personality Inventory -II from the protocol and the 
addition of the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental 
Disorders as a measure. 
 An increase in the number of subjects from 50 to 150. 
 Advertisements will now be released to the UNLV Public Relations Department. 
 Contact letters will now be sent to local psychiatrists, psychologists, and psychotherapists. 
 Participants will now be compensated monetarily at a rate of $5.00 per hour and $2.50 per half 
hour and will be given a $30.00 bonus in addition to the $5.00 per hour upon completion of the  
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 entire study. Research credits will now increase to 6 to participants from the subject pool. 
 Participants who may contact by phone will now be screened as well as verbally consented for the 
screening. 
 An additional Informed Consent will be added for individuals diagnosed with Bipolar Disorder 
from the subject pool. 
 The inclusion of a demographic form, functional outcome measure and additional symptom and 
neuropsychological assessments. 
 Three functional outcome measures will be added to the assessment battery. 
 Three neuropsychological assessments will be added. 
 One symptom measure will be added. 
 
This IRB action will not reset your expiration date for this protocol.  The current expiration date for this 
protocol is September 20, 2007. 
 
PLEASE NOTE:   
Attached to this approval notice is the official Informed Consent/Assent (IC/IA) Form for this study.  
The IC/IA contains an official approval stamp.  Only copies of this official IC/IA form may be used when 
obtaining consent.  Please keep the original for your records. 
 
Should there be any change to the protocol, it will be necessary to submit a Modification Form through 
OPRS.  No changes may be made to the existing protocol until modifications have been approved by the 
IRB. 
 
Should the use of human subjects described in this protocol continue beyond September 20, 2007, it would 
be necessary to submit a Continuing Review Request Form 60 days before the expiration date.   
 
If you have questions or require any assistance, please contact the Office for the Protection of Research 
Subjects at OPRSHumanSubjects@unlv.edu or call 895-2794. 
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Social/Behavioral IRB – Expedited Review 
Modification Approved 
 
NOTICE TO ALL RESEARCHERS: 
Please be aware that a protocol violation (e.g., failure to submit a  modification for 
any change) of an IRB approved protocol may result in mandatory remedial 
education, additional audits, re-consenting subjects, researcher probation suspension 
of any research protocol at issue, suspension of additional existing research 
protocols, invalidation of all research conducted under the research protocol at 
issue, and further appropriate consequences as determined by the IRB and the 
Institutional Officer. 
 
 
DATE:  May 16, 2007 
 
TO:  Dr. Daniel Allen, Psychology 
 
FROM: Office for the Protection of Research Subjects 
   
RE:  Notification of IRB Action by Dr. J. Michael Stitt, Chair 
Protocol Title: Neuropsychological and Emotion Processing Deficits in Adults with 
Bipolar Disorder 
Protocol #: 0510-1779 
 
 
The modification of the protocol named above has been reviewed and approved. 
 
Modifications reviewed for this action include: 
 The addition of Jamie Harnik, Michelle Sernas, Ruwida Abdel-Al, Benjamin Watrous, Paul 
Stolberg, and Audrey Garcia to the research team. 
 Additional questions about psychotic symptoms have been added to the screening process. 
 Two additional flyers have been added to the protocol. 
 
This IRB action will not reset your expiration date for this protocol.  The current expiration date for this 
protocol is September 20, 2007. 
 
Should there be any change to the protocol, it will be necessary to submit a Modification Form through 
OPRS.  No changes may be made to the existing protocol until modifications have been approved by the 
IRB. 
 
Should the use of human subjects described in this protocol continue beyond September 20, 2007, it would 
be necessary to submit a Continuing Review Request Form 60 days before the expiration date.   
 
If you have questions or require any assistance, please contact the Office for the Protection of Research 
Subjects at OPRSHumanSubjects@unlv.edu or call 895-2794. 
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Social/Behavioral IRB – Expedited Review 
Modification Approved 
 
NOTICE TO ALL RESEARCHERS: 
Please be aware that a protocol violation (e.g., failure to submit a  modification for 
any change) of an IRB approved protocol may result in mandatory remedial 
education, additional audits, re-consenting subjects, researcher probation suspension 
of any research protocol at issue, suspension of additional existing research 
protocols, invalidation of all research conducted under the research protocol at 
issue, and further appropriate consequences as determined by the IRB and the 
Institutional Officer. 
 
DATE:  February 1, 2008 
 
TO:  Dr. Daniel Allen, Pychology 
 
FROM: Office for the Protection of Research Subjects 
   
RE:  Notification of IRB Action by Dr. J. Michael Stitt, Chair 
Protocol Title: Neuropsychological and Emotion Processing Deficits in Adults with 
Bipolar Disorder 
Protocol #: 0510-1779 
 
The modification of the protocol named above has been reviewed and approved. 
 
Modifications reviewed for this action include: 
 The addition of a “Bipolar Contact Protocol.” 
 The addition of a “Consent to be Contacted for Future Studies.” 
 The addition of two funding sources from researcher Danielle Bello (Council of Graduate 
Departments of Psychology) and the NSF-EPSCoR undergraduate research award to researcher 
Sally Barney. 
 
This IRB action will not reset your expiration date for this protocol.  The current expiration date for this 
protocol is September 5, 2008. 
 
PLEASE NOTE:   
Attached to this approval notice is the official Informed Consent/Assent (IC/IA) Form for this study.  
The IC/IA contains an official approval stamp.  Only copies of this official IC/IA form may be used when 
obtaining consent.  Please keep the original for your records. 
 
Should there be any change to the protocol, it will be necessary to submit a Modification Form through 
OPRS.  No changes may be made to the existing protocol until modifications have been approved by the 
IRB. 
 
Should the use of human subjects described in this protocol continue beyond September 5, 2008, it would 
be necessary to submit a Continuing Review Request Form 60 days before the expiration date.   
 
If you have questions or require any assistance, please contact the Office for the Protection of Research 
Subjects at OPRSHumanSubjects@unlv.edu or call 895-2794. 
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Social/Behavioral IRB – Expedited Review 
Modification Approved 
 
NOTICE TO ALL RESEARCHERS: 
Please be aware that a protocol violation (e.g., failure to submit a  modification for 
any change) of an IRB approved protocol may result in mandatory remedial 
education, additional audits, re-consenting subjects, researcher probation suspension 
of any research protocol at issue, suspension of additional existing research 
protocols, invalidation of all research conducted under the research protocol at 
issue, and further appropriate consequences as determined by the IRB and the 
Institutional Officer. 
 
 
DATE:  July 14, 2008 
 
TO:  Dr. Daniel Allen, Psychology 
 
FROM: Office for the Protection of Research Subjects 
   
RE:  Notification of IRB Action by Dr. J. Michael Stitt, Chair 
Protocol Title: Neuropsychological and Emotion Processing Deficits in Adults with 
Bipolar Disorder 
Protocol #: 0510-1779 
 
The modification of the protocol named above has been reviewed and approved. 
 
Modifications reviewed for this action include: 
 The addition of Alex Hutchings to the research team. 
 
This IRB action will not reset your expiration date for this protocol.  The current expiration date for this 
protocol is September 5, 2008. 
 
Should there be any change to the protocol, it will be necessary to submit a Modification Form through 
OPRS.  No changes may be made to the existing protocol until modifications have been approved by the 
IRB. 
 
Should the use of human subjects described in this protocol continue beyond September 5, 2008, it would 
be necessary to submit a Continuing Review Request Form 60 days before the expiration date.   
 
If you have questions or require any assistance, please contact the Office for the Protection of Research 
Subjects at OPRSHumanSubjects@unlv.edu or call 895-2794. 
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